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Abstract 
Achieving equality in the distribution of health care services, in the form of equal use 
for equal need, is an objective for many health care systems. This study investigates 
inequality in the supply of Percutaneous Coronary Intervention (PCI) treatment for 
Acute Myocardial Infarction (AMI) in Norway during the years 1999 to 2007. The 
study aims to assess whether consumption of PCI varies with need, or whether the 
consumption varies with other factors such as age, gender, socioeconomic status 
(SES), distance to treatment centre and geographical location.  
The numbers of AMI-patients and PCI-treatments are gathered from all hospital 
admissions during the period of analysis. The explanatory variables are analysed for 
their effects on the dependent variable, the probability of PCI (
AMI
PCI ). 
The analysis is performed as a multiple linear regression analysis with dummy 
variables for Hospital Trusts and years. 
The results show an increase in the probability of PCI from 1999 – 2007 for the 
whole of Norway. The main result of this study is that there are significant 
differences in the probability of PCI during the period of analysis. The differences are 
relatively large in the beginning of the period. Due to decreasing differences with 
time, the differences are relatively small in the end of the period of analysis. 
The independent variables with significant results are age, gender, mortality from 
ischemic heart diseases, population share above 80 years, distance to PCI-treatment 
centre, eighteen dummies for Hospital Trusts and seven year dummies. 
 7 
Table of Contents 
ACKNOWLEDGEMENTS .................................................................................................................3 
ABBREVIATIONS AND ACRONYMS.............................................................................................4 
ABSTRACT ..........................................................................................................................................6 
TABLE OF CONTENTS .....................................................................................................................7 
TABLE OF FIGURES .......................................................................................................................10 
TABLE OF TABLES .........................................................................................................................11 
1. ....................................................................................................................13 INTRODUCTION
1.1 ........................................................................................................16 MEDICAL BACKGROUND
1.2 ...........................................................................19 EQUAL ACCESS TO HEALTH CARE SERVICES
1.3 .....................................................................................................................................20 DATA
2. ..................................................................................................22 MEDICAL INFORMATION
2.1 .......................................................................................................................................22 AMI
2.2 .........................................................................................................................24 DIAGNOSTICS
2.3 .............................................................26 TREATMENT: PCI VERSUS THROMBOLYTIC THERAPY
2.4 ...................................................................................28 GUIDELINES FOR TREATMENT OF AMI
3. ....................30 INSTITUTIONAL DETAILS AND THEORETICAL CONSIDERATIONS
3.1 ...................................................................30 THE NORWEGIAN PUBLIC HEALTH CARE SYSTEM
3.2 ...........................32 POSSIBLE FINANCIAL EFFECTS ON THE ACCESS TO HEALTH CARE SERVICES
3.3 .........................................34 THE RELATIONSHIP BETWEEN NEED, DEMAND AND CONSUMPTION
3.4 ......................................................................39 NEED/DEMAND SIDE INDEPENDENT VARIABLES
3.4.1 ..............................................................................................................................39 Age
3.4.2 ........................................................................................................................40 Gender
 8 
3.4.3 ............................................................................................................................. 42 SES
3.4.4 .................................................................................................... 44 Mortality from IHD
3.5 ................................................................................. 45 SUPPLY SIDE INDEPENDENT VARIABLES
3.5.1 ........................................................................................................... 45 Travel distance
3.5.2 ............................................................. 48 HT and year dummy variables (fixed effects)
3.6 ............................................................................................................................. 49 SUMMARY
4. ........................................................................................................... 52 DATA AND METHOD
4.1 .................................................................................................... 52 ETHICAL CONSIDERATIONS
4.2 ............................................................................................................................ 52 NPR-DATA
4.3 ....................................................................... 53 DEPENDENT VARIABLE: PROBABILITY OF PCI
4.4 .......................................................................................................... 54 OTHER DATA SOURCES
4.5 ................................................................... 54 EXTRAPOLATION: CENTERED MOVING AVERAGE
4.6 ................................................................................................ 55 STATISTICAL ANALYSIS TOOL
4.7 ................................................................................................................ 55 EMPIRICAL MODEL
4.8 ....................................................................................................................... 57 ASSUMPTIONS
4.8.1 .................................................................................................................... 57 Statistical
4.8.2 ................................................................................................................. 58 Methodical
4.9 ....................................................................................................... 59 DESCRIPTIVE STATISTICS
5. ................................................................................................................................. 64 RESULTS
5.1 ............................................................................................... 67 RESEARCH QUESTION 1 AND 2
5.2 ............................................................................................... 68 RESEARCH QUESTION 3 AND 4
5.3 ......................................................................................................... 72 RESEARCH QUESTION 5
6. ........................................................................................................................... 73 DISCUSSION
6.1 ......................................................................................... 73 TOPIC AND PROBLEM STATEMENT
 9 
6.2 ......................................................................................................................73 MAIN FINDINGS
6.3 ........................................................................................................74 DISCUSSION OF RESULTS
6.4 ..........................................................................................................................77 LIMITATIONS
7. .........................................................................................................................79 CONCLUSION
KILDELISTE......................................................................................................................................80 
APPENDIX..........................................................................................................................................85 
 
 10 
Table of Figures 
Figure 1.1 Total number of AMI caused deaths per 100 000 population................... 17 
Figure 1.2 Geographical locations of PCI-treatment centres. Areas covered by 90 
minutes travel time with ambulance and helicopter. .................................................. 19 
Figure 2.1 Number of reported AMI during the period 1999 – 2007. ....................... 23 
Figure 2.2 Number of reported AMI per 100 000 population during the period 1999 – 
2007............................................................................................................................. 23 
Figure 2.3 Stages in the diagnosing of AMI............................................................... 25 
Figure 2.4 To the left: Drawing of the PCI procedure with balloon pump. To the 
right: Drawing of the PCI procedure with stent.......................................................... 27 
Figure 2.5 Time from occlusion to fatal damage/death of heart muscle cells............ 28 
Figure 3.1 The relation between health status, SES-variables, need, supply and 
consumption of health care services. .......................................................................... 35 
Figure 3.2 Mortality from IHD per 100 000, 1951 – 2003......................................... 41 
Figure 3.3 Catchment areas for PCI-centres, 1999 – 2002......................................... 46 
Figure 3.4 Catchment areas for PCI-centres in South (South-East) RHA, 2003 – 
2007............................................................................................................................. 47 
Figure 4.1 Probability of PCI per age group, 1999 – 2007. ....................................... 63 
Figure 5.1 Probability of PCI as a function of “Age” and “(Age) ”.2 ......................... 66 
 
 11
Table of Tables 
Table 1.1 ICD-10 codes included in the data set containing only AMI admissions. . 21 
Table 1.2 NCMP/NCSP procedure codes for PCI-treatment. .................................... 21 
Table 3.1 Hospital Trusts with PCI-centres, geographical location and Regional 
Health Authority.......................................................................................................... 31 
Table 3.2 Change in basic grants to RHAs, historic level of basis grants and grants 
based 100% on cost keys (mill. 2003-NOK). ............................................................. 33 
Table 3.3 Basic grants to RHAs in 2003 (mill. 2003-NOK). ..................................... 34 
Table 3.4 Catchment areas for the hospitals offering PCI treatment in West Norway 
RHA used in the analysis. ........................................................................................... 48 
Table 3.5 Definition of independent variables............................................................ 50 
Table 4.1 Descriptive statistics of variables, 1999 – 2007. ........................................ 59 
Table 4.2 Descriptive statistics of AMI and PCI per 10-year age group, 1999 – 2007.
..................................................................................................................................... 62 
Table 5.1 Results obtained from the regression analysis, 1999 – 2007...................... 64 
Table 5.2 Results from test of effects within the group of HTs with PCI-treatment 
centre, 1999 – 2007. .................................................................................................... 69 
Table 5.3 Results from test of effects within the group of HTs with PCI-treatment 
centre, 2007. ................................................................................................................ 69 
Table 5.4 Results from test of effects within the group of HTs without PCI-treatment 
centre, 1999 – 2007. .................................................................................................... 70 
 12 
Table 5.5 Results from test of effects within the group of HTs without PCI-treatment 
centre, 2007................................................................................................................. 71 
7.1 HT numbers, name and PCI-centre ...................................................................... 85 
 
 13
1. Introduction 
Norway is one of the worlds most wealthy countries and has for several years been on 
the top of The Human Development Index (HDI) (United Nations Development 
Programme 2008). The welfare state of Norway is known to be very comprehensive; 
the state providing amongst others safety, education and national health- and pension 
insurances for its citizens. Equality for all citizens is the primary goal for the 
distribution of public services, within public health precisely defined in the 
commission documents from The Royal Norwegian Ministry of Health and Care 
Services to the four Regional Health Authorities (RHA) in 2009 as follows: “The 
primary goal for the health care sector is to provide adequate and appropriate health 
care services for everyone in Norway, irrespective of individual financial 
circumstances, social status, age, sex and ethnicity” (Helse- og omsorgsdepartementet 
2009b). 
Main determinants of health are hereditary factors, individual lifestyle factors and 
general socioeconomic, cultural and environmental factors. In addition to this, 
inequalities in health care access and consumption may influence cure or survival 
from diseases, accidents and other life threatening or life quality reducing conditions 
(Manson-Siddle and Robinson 1998). The pursuit of equality as a key objective for 
the distribution of and the access to public health care services, has lead to a 
financing of the RHAs and the Hospital Trusts (HT) which seek to compensate for 
the differences in demography, dispersed settlements and Socio Economic Status 
(SES) found in Norway. Despite this, there has been revealed inequalities in the 
general access to health care services and variations in consumption per capita due to 
general practitioner (GP) coverage, distance to hospital and different geographical 
locations in Norway (Nerland and Hagen 2008). 
The present study is designed to investigate more specifically the access and 
variations in the consumption of treatment for acute myocardial infarction (AMI) in 
Norway during the period 1999 – 2007. In the 1990’s percutaneous coronary 
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intervention (PCI) developed as the recommended treatment method for AMI. 
Thrombolytic therapy (pharmacological treatment) is administered if primary PCI is 
not immediately available. Primary PCI trials suggest lower mortality rates for AMI 
when PCI-treatment is given compared with thrombolytic treatment alone (Spinler et 
al. 2001). Because of the advanced technology and the necessity for cardiology 
specialists performing the PCI-intervention, PCI-treatment is centralised to six (after 
2002 seven) secondary care HTs in Norway. 
Evidence from several countries indicate that the access to and the supply of 
treatment for cardiovascular disease, and especially AMI, is unequally distributed. In 
Canada, rates of revascularisation (PCI and CABG1) are higher in the western 
provinces than elsewhere (Johansen et al. 1998). In the United States substantial 
geographical variation in the treatment of AMI is pointed out (O'Connor et al. 1999). 
In England, socioeconomic variations in investigation and revascularisation within 
the former Yorkshire Region are found, suggesting unequal supply of treatment. The 
deprived in the region consume less treatment relative to their need than the affluent. 
Also, small areas that are close to cardiology centres have high rates of investigation 
and surgery, while more remote areas tend to have fewer procedures (Manson-Siddle 
& Robinson 1998). In Scotland, variations in investigation and revascularisation are 
demonstrated by age, sex, geography and socioeconomic deprivation (MacLeod et al. 
1999). 
This study investigates inequality in the probability of getting PCI-treatment for AMI 
(probability of PCI) in Norway during the years 1999 to 2007. The main research 
question is: 
1) Is there significant evidence for unequal access, measured as varying 
probability of PCI, in Norway in the period of analysis? 
Secondly, if indeed there is significant evidence of unequal access: 
                                              
1 CABG-treatment (Coronary Artery Bypass Graft) is a treatment for AMI given to a large extent as elective treatment. 
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2) Is there significant evidence for an unequal probability of PCI between those 
patients living in the catchment area of HTs with PCI-treatment and those 
living in the catchment area of HTs without PCI-treatment? 
3) Is there significant evidence for an unequal probability of PCI within the 
group of HTs with PCI?  
4) Is there significant evidence for an unequal probability of PCI within the 
group of HTs without PCI?  
5) Are demographical variables, SES-variables and geographical location 
independently associated with the probability of PCI? 
A data set containing all in-patient visits to Norwegian HTs is used to identify 
patients admitted with AMI between 1999 and 2007. The proportion given PCI-
treatment during their hospital stays is identified by their procedure code and the 
probability of getting PCI ( 
AMI
PCI  ) is calculated. The probability of PCI is used as the 
dependent variable in a multiple linear regression analysis. Age, gender, SES-
variables, mortality from ischemic heart disease and distance to treatment centre are 
used as independent variables to investigate if some of these are independently 
associated with the probability of PCI. Dummies for HTs and years are included in 
the analysis to capture the unequal supply side effects between the HTs and between 
the years. The data is handled and analysed with the statistical software SAS. 
The results show an increase in the probability of PCI from 1999 – 2007 for the 
whole of Norway. A significant variation in geographical location is detected; 
patients living in the catchment area to a Hospital Trust without PCI-treatment centre 
have a lower probability of PCI than patients living in the catchment area of a 
Hospital Trust with PCI-treatment centre.  
Other independent variables with significant results are age, gender, population share 
above 80 years, distance to PCI-treatment centre and mortality from ischemic heart 
disease. 
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1.1 Medical background 
Cardiovascular diseases are the number one cause of death and are projected to 
remain so both globally and in Norway (Nasjonalt folkehelseinstitutt 2002;WHO 
2009a). Cardiovascular diseases include coronary heart disease (AMI), 
cerebrovascular disease, raised blood pressure (hypertension), peripheral artery 
disease, rheumatic heart disease, congenital heart disease and heart failure. In Norway 
during the period of analysis, 12 000 to 20 000 cases of AMI were registered every 
year (NPR data for the years 1999 – 2007). Among the cardiovascular diseases AMI 
is the most common cause of death. The mortality rate through the last 25 years is 
halved for AMIs (see Figure 1.1), but whether this is a result of less people than 
before experiencing AMI (prevention effect) or whether this is a result of lower 
mortality rates amongst those having an AMI (treatment effect) is not known for 
certain (Nasjonalt folkehelseinstitutt 2002). 
 17
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Figure 1.1 Total number of AMI caused deaths per 100 000 population. 
(Statistisk Sentralbyrå 2009). 
Norway is a country with densely populated urban areas along side with smaller 
coastal communities and scattered inland settlements. A long coastline, urban cities, 
forests and mountainous areas contribute to a great variety in the physical 
environment for the inhabitants of Norway. This variety is bound to create some 
differences in economic activity and lifestyles across the country and the resulting 
variation in income and access to public services do not follow the political ideology 
of equality for all citizens (Nerland & Hagen 2008). 
Being investigated in this study is the possible inequality in the access to PCI-
treatment. A National Health Insurance for all citizens in Norway ensures that the 
patients do not have to pay out of pocket for necessary treatments like PCI-treatment 
for AMI. The Norwegian State, through the ownership of the RHAs and the HTs, has 
the responsibility of supplying necessary treatment, such as PCI-treatment, equally to 
all citizens according to their need. 
The two main treatments for AMI are PCI and thrombolytic therapy. Thrombolytic 
therapy is a medical treatment given intravenously and is not dependent on being 
administered by cardiologists. PCI-treatment on the other side is defined as a highly 
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technological invasive procedure performed by cardiologists. PCI is recommended as 
standard treatment because of a lower death-rate and fewer re-infarctions and strokes 
(see chapter 2.3). Guidelines for establishment of medical procedures advise that 
there should only be established PCI-treatment centres where day and night 
preparedness is justifiable due to population- and transportation conditions. There 
should be at least 400 patients a year, meaning about 300 000 people living in the 
catchment area of the HT to justify an establishment of a PCI-treatment centre. In 
addition, the transportation to the HT has to be organised in an appropriate way so 
that the travel time to the hospital is minimised (Sundar 2003). The varying physical 
environment and scattered population of Norway clearly do not justify establishment 
of PCI-treatment centres in all parts of the country without an extensive 
transportation plan including helicopter transportation in many places. Such a standby 
preparedness is very expensive and during the period 1999 – 2007 there were 
established six (seven after 2002) PCI-treatment centres in Norway (see chapter 3.1.). 
The geographical location of the PCI-treatment centres and the areas covered by the 
90 minutes travel time criteria for PCI with ambulance and helicopter is shown in 
Figure 1.2. (see chapter  2.4) (Bendz 2009). Extra treatment capacity is indicated by 
dotted circles (Arendal and Oslo). Thrombolytic therapy is the alternative if PCI is 
not available. In the period 1999 – 2007 the hospital in Bodø (Nordlandssykehuset 
HT) did not perform any PCI-treatments. 
 19
 
 
Figure 1.2 Geographical locations of PCI-treatment centres. Areas covered 
by 90 minutes travel time with ambulance and helicopter.  
(Bendz 2009). 
1.2 Equal access to health care services 
The welfare state of Norway and its aim of providing fair, just and equal services for 
all citizens is in many ways similar with how Daniels (Daniels 1985) argues for 
“equality of opportunity" as a fair and just way of allocating scarce resources. Every 
citizen has a legal right to have their share of the normal opportunity range protected 
by the society. By offering public health services and national health insurances the 
Norwegian welfare state seek to protect each citizen’s normal opportunity range from 
being lowered or harmed unnecessarily by health problems.  
Public health care systems across the world, like the National Health Service (NHS) 
in the UK (Gatrell et al. 2002;Morris et al. 2005),  the New Zealand public health 
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system (Peacock et al. 1999), the Dutch public health system (ter Meulen and van der 
Made 2000), the Norwegian public health system (Iversen and Kopperud 2002a) and 
many others, have this pursuit of equality as a key objective for their distribution of, 
and their access to, public health care services. Because equality can be defined in 
many ways, a common understanding of equality in a health care service context is 
useful. Elster’s (Elster 1989) theories of distributive justice give examples of different 
principles that can be followed when resources are to be allocated in a just way. The 
principle of distribution according to need defines equality as equal consumption for 
equal need, and the The Royal Norwegian Ministry of Health and Care Services rests 
on this definition of equality in its work for a fair and just allocation of health care 
resources. This definition of equality will also be used in this thesis. 
1.3 Data 
The data is gathered from all in-patient data in Norway during the years 1999 to 2007 
reported to the Patient register of Norway (Norsk Pasientregister (NPR)). A selection 
of the NPR-data based on the main diagnosis for AMI is made. The diagnosis for 
AMI is identified from ICD-102, see Table 1.1. 
                                              
2 International Statistical Classification of Diseases and Related Health problems, 10th Revision, version for 2007. 
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Table 1.1 ICD-10 codes included in the data set containing only AMI 
admissions. 
ICD-10 code Description 
I21 Acute myocardial infarction  
I21.0 Acute transmural myocardial infarction of anterior wall  
I21.1 Acute transmural myocardial infarction of inferior wall  
I21.2 Acute transmural myocardial infarction of other sites  
I21.3 Acute transmural myocardial infarction of unspecified site  
I21.4 Acute subendocardial myocardial infarction  
I21.9 Acute myocardial infarction, unspecified  
I22 Subsequent myocardial infarction  
I22.0 Subsequent myocardial infarction of anterior wall  
I22.1 Subsequent myocardial infarction of inferior wall  
I22.8 Subsequent myocardial infarction of other sites  
I22.9 Subsequent myocardial infarction of unspecified site  
(WHO 2009b) 
The data set containing only AMI admissions contained 147 396 observations. This 
data set is used in the further analyses. The proportion of the 147 396 AMI 
admissions given PCI-treatment during their hospital stay is identified by their 
NCMP and NCSP procedure code3 . 
Table 1.2 NCMP/NCSP procedure codes for PCI-treatment. 
NCSP procedure code Description 
FNG Expansion and recanalisation of coronary artery 
FNG 02 Percutaneous transluminal coronary angioplasty 
FNG 05 Percutaneous transluminal coronary angioplasty with insertion of stent
(KITH 2008;NOMESCO 2007) 
Statistics Norway (SSB) and Norwegian Social Science Data Services (NSD) provide 
information about demography and SES-variables. A matrix over the distances in 
kilometres from each municipality centre to the centre of the hospital municipality, 
prepared and calculated by InfoMap Norge AS (Iversen and Kopperud 
2002b;Kopperud 2002), is also included in the analysis. 
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2. Medical information 
2.1 AMI 
Acute myocardial infarction (AMI) is a frequent cause of mortality and morbidity in 
Norway and in other Western industrialised countries. 12 000 – 20 000 cases of AMI 
is registered in Norway every year (NPR data for the years 1999 – 2007, see Figure 
2.1) and elderly patients are especially in the risk group. The mean age for AMI in 
the period of analysis is 70 years and the death-rate from AMI increases with the 
patient’s age (Jortveit and Brunvand 2006). 
Each individual’s genes and hereditary characteristics have impact on the probability 
of experiencing AMI. Some people inherit genes with a tendency of causing high 
cholesterol levels. Hereditary factors will therefore together with risk factors play a 
part when a person’s probability of getting AMI is decided. High cholesterol levels 
are the main risk factor for AMI for both men and women. Other risk factors are 
smoking, elevated blood pressure, diabetes and obesity. Physical activity and 
consumption of fruits and vegetables are protective (Nasjonalt folkehelseinstitutt 
2008). Recent studies suggest that shift work and night work are risk factors for 
cardiovascular diseases. Long work days and small amounts of sleep are also 
associated with negative health effects, and especially with cardiovascular diseases. 
Due to methodological problems the studies investigating the relationship between 
stress and cardiovascular diseases can not make any final conclusions (Kjuus 2008). 
Data from Norwegian health surveys imply that smoking, unhealthy lifestyle, obesity, 
little physical activity and diabetes are strongly socially skewed (Nasjonalt 
folkehelseinstitutt 2007b) implying that people with low SES are exposed to more 
risk factors for AMI than others. 
                                                                                                                                           
3 The NOMESCO Classification of Medical and Surgical Procedures 
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Figure 2.1shows number of reported AMI-admissions in Norway during the period 
1999 – 2007. 
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Figure 2.1 Number of reported AMI during the period 1999 – 2007. 
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Figure 2.2 Number of reported AMI per 100 000 population during the 
period 1999 – 2007. 
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Figure 2.1and Figure 2.2 show that there is a steady growth in the numbers of 
diagnosed AMIs from 2000 until 2006/2007 when the growth seems to stagnate. 
However, in the 1990s there was a decrease in the numbers of diagnosed AMIs. After 
year 2000 this trend was replaced by an increase in the numbers of diagnosed AMIs 
instead. This increase of diagnosed AMIs seems to be the result of a set of new 
cardiac markers/bio markers (troponin) used in the diagnostics of AMI and not as a 
result of increased incidence of AMI (Hagen and Reikvam 2003;Nordrehaug 2001). 
2.2 Diagnostics 
When diagnosing AMI, typical increase and gradual reduction of troponin or rapid 
increase and reduction of CK-MB (Creatine Kinase) are used as main criteria. In 
addition, at least one of the following criteria should be present: symptoms of 
ischemia/chest pains, development of pathological Q waves in electrocardiogram 
(ECG) or ischemic ECG changes (ST-elevation/depression). 
Figure 2.3 shows different stages in the diagnosing of AMI. Model 1 represents a 
stenotic (narrowed) part of a coronary artery with segments built up of cholesterol 
laden plaques. The ECG is non-striking and there is no extra release of troponin 
(troponin -). Model 2 shows a leakage in the capsule that envelops the cholesterol 
laden plaques. When the plaques and blood creates a contact surface, additional 
thrombosis (blood clot) is created. The coronary artery narrows further and because 
the blood stream is considerably reduced, a ST depression shows at the ECG. An 
unstable angina is different from a non-ST elevation infarction (non-STEMI) because 
the latter has an increase in troponin or other cardiac markers indicating myocardial 
damage. Model 2 indicates no extra release of troponin (troponin -). Model 3 shows 
considerable thrombosis. Parts of the thrombus drift with the blood and cause micro 
infarctions which increase the level of troponin (troponin +). The name “non-
STEMI” arose from the fact that there is no ST elevation (non-STE) and “MI” for 
myocardial infarction. Model 4 shows a total blockage of the coronary artery. 
Because of the standstill in the blood stream, the ECG shows a ST elevation. 
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Troponin is released (troponin +) and if the artery is not re-opened the patient will get 
a heart attack (AMI/MI) (Helse Vest RHF 2003). 
 
Model 1: Stable angina Troponin 
-
ST depression
Troponin 
-
Model 2: Unstable angina
ST depression
Troponin 
+
Model 3: Non-ST elevation
infarction (non-STEMI) 
ST elevation
Model 4: ST elevation 
Troponin 
+
infarction (STEMI) 
Figure 2.3 Stages in the diagnosing of AMI. 
(Helse Vest RHF 2003) 
The use of troponin in AMI diagnostics was in the year 2000 together with CK-MB 
recommended by The Joint European Society of Cardiology and by the American 
College of Cardiology Committee for the Redefinition of Myocardial Infarction as 
part of the routine diagnostics of AMI. The number of cases of AMI was predicted to 
increase because of the better diagnostics as the troponins point out myocardial 
damage also in cases where the patient has a normal CK-MB-value. For Norway, this 
was predicted to lead to an increase in number of persons getting the diagnose AMI 
to an extra 1 000 – 2 000 persons per year (Nordrehaug 2001). As pointed out in 
chapter 2.1 there is an increase in the number of diagnosed AMI cases between 2000 
and 2001. Taking into account that cases and persons are different units (one person 
may cause several cases due to several heart attacks or transfer from one hospital to 
another) the data seems to comply with the estimates made by Nordrehaug. 
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2.3 Treatment: PCI versus thrombolytic therapy 
If the coronary arteries, which work as the blood suppliers to the heart, are blocked 
(occlusion) and the blood circulation can not be re-established, the heart muscles 
peripheral for the occlusion will be damaged or die. This is called myocardial 
infarction (MI) or acute myocardial infarction (AMI). AMI (I21 – I22) is the 
diagnosis being further investigated in this study. There are two main treatments for 
AMI. Thrombolytic therapy (medical treatment of decomposition of blood 
clot/thrombosis) is meant to help the thrombosis in the narrowing in the coronary 
artery to dissolve so that the coronary circulation can be re-established. Thrombolytic 
therapy is given intravenously and is not dependent on being administered by 
specialists in cardiology. Percutaneous Coronary Intervention (PCI) is a non-medical 
treatment for AMI, which mechanically expands the coronary artery, see Figure 2.4. 
A catheter is lead through the narrowed part of the coronary artery and a balloon is 
inflated to block out the occluded area. A stent can be used to permanently keep the 
earlier stenotic area open, but the intervention can also be done without stent. The 
stent will be left in the artery after the catheter is removed. PCI treatment demands 
advanced technological equipment and specialized personnel (Grut 2007). 
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Figure 2.4 To the left: Drawing of the PCI procedure with balloon pump. To 
the right: Drawing of the PCI procedure with stent. 
(Helse Vest RHF 2003) 
The effect of both thrombolytic therapy and PCI treatment is dependent of how fast 
the treatment is started after the occlusion. Damaged or destroyed heart muscles can 
not be regained and thus makes the time factor very important. Time from occlusion 
to the death of heart cells is illustrated in Figure 2.5: 
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Figure 2.5 Time from occlusion to fatal damage/death of heart muscle cells. 
(Helse Vest RHF 2003). 
For every hour the treatment is delayed, the mortality from AMI increases. The faster 
the treatment is started, the less is the probability of both acute and long-term 
mortality. Also, the risk for a new AMI, complications like cerebral infarction and 
long in-patient stays are lowered (Helse Vest RHF 2003). 
”Norsk legemiddelhåndbok” (Norsk legemiddelhåndbok 2009) and the report: “PCI 
ved akutt hjerteinfarkt. SMM-rapport nr. 5/2002” (Sundar 2003) recommend PCI as 
standard treatment for AMI. Compared with thrombolytic treatment, PCI leads to 
lower mortality and fewer re-infarctions and strokes. 
2.4 Guidelines for treatment of AMI 
If patients with AMI are less than 90 minutes from a hospital offering PCI-treatment, 
PCI is preferred over thrombolytic therapy. If the symptoms of AMI have been 
present for less than 3 hours and the travel time to the nearest invasive centre (PCI 
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centre) is more than 90 minutes, thrombolytic therapy is recommended. If there have 
been symptoms for more than 3 hours PCI-treatment is recommended (Norsk 
legemiddelhåndbok 2009). 
In addition, different guidelines within the RHAs may specify the treatment of AMI 
within the region due to special regional conditions (Helse Vest RHF 2003). 
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3. Institutional details and theoretical 
considerations 
3.1 The Norwegian public health care system 
The Norwegian health care sector with the Royal Norwegian Ministry of Health and 
Care Services as the office in charge has the overall responsibility for government 
policy on health care services in Norway. The primary goal for the health care sector 
is to provide adequate and appropriate health care services for everyone in Norway, 
irrespective of geographical location, financial circumstances, social status, age, sex 
and ethnical background (Helse- og omsorgsdepartementet 2007;Helse- og 
omsorgsdepartementet 2009b). 
The primary care, supplied by the municipalities after law number 66 of November 
the 19th 1982, covers nursing and care services, emergency wards, midwife services 
and GPs for the citizens of the municipality. The secondary care covers all other 
health care services not included in the primary care (Helse- og 
omsorgsdepartementet 2006). In 2002 the RHAs were given the responsibility for the 
secondary health care services. The supply of secondary care services were organised 
in HTs, which primarily where the old hospitals earlier owned by the counties in 
Norway. Each HT was assigned a catchment area (municipalities) which the HT 
should provide adequate health care services to, according to the need of the 
population. 
The merge of the Regional Health Authority East and the Regional Health Authority 
South in the middle of 2007 did not have any impact on the supply of AMI treatment. 
The catchment areas in the period being analysed were not altered and are therefore 
equally treated in the analysis before and after the merge. 
The tertiary care is the highly specialised hospitals with national responsibilities. 
These hospitals may have both primary- and secondary care responsibilities in 
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addition, but certain specialised services can be given a tertiary care status meaning 
that patients from the whole of Norway can be referred treatment at this hospital. 
PCI-treatment for AMI was in the period 1999 – 2002 assigned to six secondary care 
HTs which were meant to meet the demand for PCI-treatment of AMI within their 
RHA. From 2003 – 2007 there were seven secondary care HTs offering PCI-
treatment. 
Table 3.1 Hospital Trusts with PCI-centres, geographical location and 
Regional Health Authority. 
Hospital Municipality Regional Health Authority 
Rikshospitalet HT Oslo South Norway RHA* 
Sørlandet Sykehus HT (after 2002) Arendal South Norway RHA* 
Ullevål Universitetssykehus HT Oslo East Norway RHA* 
Stavanger Universitetssykehus HT Stavanger West Norway RHA 
Haukeland Universitetssykehus HT Bergen West Norway RHA 
St. Olavs Hospital HT Trondheim Mid Norway RHA 
Universitetssykehuset Nord-Norge 
HT Tromsø North Norway RHA 
* Merged to South East Norway RHA summer 2007. 
The catchment areas of the HTs were often coincident with county areas. In the 
period of the analysis there were 26 HTs established in Norway, see table 7.1 in the 
appendix. 
One private hospital in Eidsvoll municipality, Feiringklinikken AS, also offered PCI-
treatment during the period of analysis. This private hospital is not included in the 
analysis. Feiringklinikken AS is not comparable to the other HTs due to its status as a 
private hospital without a catchment area. Instead patients are given elective 
treatment, meaning that Feiringklinikken receives referrals from all parts of Norway 
according to agreements with the RHAs. The relatively few cases of PCI-treatment at 
Feiringklinikken compared to the cases from the HTs support the decision of 
excluding Feiringklinikken from the analysis. 
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3.2 Possible financial effects on the access to health care 
services 
Even though the financing of the somatic health care activity during the period of this 
study has changed according to the Activity Based Financing (ABF) (ABF share 
ranging from 40% to 60%), the concept of supply of health care services according to 
need has been kept as a main objective. The establishment in 2002 of five Regional 
Health Authorities with provider responsibility for the citizens did not change this. 
The RHAs’ somatic income in the period being analysed consisted of a basis granting 
and an ABF based granting. With these resources the RHAs were responsible for 
supplying somatic health care services to its citizens according to their needs4. The 
resources allocated to the RHAs have been discussed and investigated during the 
period of analysis and also in later years (Carlsen 2006;NOU 2003:1 2003;NOU 
2008:2 2008). Especially the North Norway RHA has been subject for discussions 
about the size of the basis granting given to this RHA. Table 3.2 shows the basis 
grants (BG) for 2003 as they would have been if they were based on the amounts 
given in earlier grants. The effects on the basis grants if the grants were 100% based 
in the cost keys suggested in NOU 2003:1 are also shown. The cost keys included 
travel distance, defined as share of population with travel time more than 1,5 hours to 
nearest hospital, and age criteria (proportion of citizens in different age groups). The 
age criteria were weighted with 96% of the total cost key while the travel distance 
was weighted to 4% (NOU 2003:1 2003). 
                                              
4 The RHAs also have the responsibility for other health care services such as habilitation, rehabilitation, mental health 
care, treatment for alcohol and drug dependency etc. in addition to the responsibility for education, research etc. These 
areas are outside the scope of this study and are therefore not investigated further.   
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Table 3.2 Change in basic grants to RHAs, historic level of basis grants and 
grants based 100% on cost keys (mill. 2003-NOK). 
  EN RHA SN RHA WN RHA MN RHA NN RHA Sum 
BG 2003 
 17 
476,00   9 931,00  8 980,00  6 726,00  5 848,00  
 48 
961,00  
BG, cost keys (100%)
 17 
351,00   9 571,00  9 675,00  7 048,00  5 316,00  
 48 
961,00  
Change in NOK (mill.)
     
(125,00) 
   
(360,00)     695,00     322,00 
   
(532,00)             -    
Change in percent 
        
(0,70) 
      
(3,60)        7,70        4,80 
      
(9,10)   
BG=Basis grant, EN=East Norway, SN=South Norway, WN= West Norway, 
MN=Mid Norway, NN=North Norway 
(Helse- og omsorgsdepartementet 2003) 
It was especially paid attention to the negative effects for North Norway RHA. Thus, 
in the final basis grants from the Royal Norwegian Ministry of Health and Care 
Services to the RHAs these effects were levelled out by basing only 50% of the basis 
grants on the suggested cost keys, leaving 50% to the historic level of basis grants to 
the RHAs. In addition, redistributing of “the North Norway grant”5, income covering 
depreciation and other grants given in 2003 to the RHAs resulted in the following 
basis grants: 
                                              
5 The “North Norway grant” was financed by the other RHAs achieving larger amounts of basis granting due to NOU 
2003:1. 
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Table 3.3 Basic grants to RHAs in 2003 (mill. 2003-NOK). 
  EN RHA SN RHA WN RHA MN RHA NN RHA Sum 
BG 2003 
 17 
476,00   9 931,00  8 980,00  6 726,00  5 848,00  
 48 
961,00  
50% cost key, 50% 
Historic BG, "North 
Norway grant", 
income depreciation, 
other grants 
 17 
400,00   9 751,00  9 187,00  6 827,00  5 796,00  
 48 
961,00  
Change in NOK (mill.)
      
(76,00) 
   
(180,00)     216,00       92,00 
     
(52,00)             -    
Change in percent 
        
(0,40) 
      
(1,80)        2,40        1,40 
      
(0,90)   
BG=Basis grant, EN=East Norway, SN=South Norway, WN= West Norway, 
MN=Mid Norway, NN=North Norway 
(Helse- og omsorgsdepartementet 2003) 
The negative effects for North Norway RHA were compensated for as Table 3.3 
shows. This left the RHAs with only minor changes in their basis grants both 
compared to what they previously had got and to what they would have got if the cost 
keys were implemented 100%. 
The allocation of financial resources to the RHAs is meant to give them the same 
opportunities to develop equal health care services across the whole of Norway. Yet, 
there has been revealed inequalities in the access to health care services in Norway 
(Nerland & Hagen 2008) and the allocation of resources to the RHAs thus may affect 
the equality of health care services in Norway. 
3.3 The relationship between need, demand and 
consumption 
When defining equality as equal consumption for equal need (see chapter 1.2) it 
follows that there is equality if relative differences in consumption reflects the same 
relative differences in need. The need for health care services, however, is difficult to 
measure exactly. 
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The need for health care services on an aggregated level is based on subjective 
considerations of individual need. Individual need is normally considered to be a 
result of the individual health status and the present medical technology which 
together decide the individual’s possibility to utilize the given health care services. 
The health status and the possibility of utilization of health care services may again 
differ according to factors like age and different SES-variables. Figure 3.1 shows the 
relation between health status, SES-variables, need, supply and demand for health 
care services. 
 
 
 
H: Health status 
X: 
SES characteristics (including gender and 
age) 
B: Need (unobserved) 
F: Consumption of health care services 
T: Supply side characteristics 
 
Figure 3.1 The relation between health status, SES-variables, need, supply 
and consumption of health care services. 
 (NOU 2008:2 2008). 
The need for health care services (B) occurs as a result of normal conditions like 
giving birth, regular screening programmes and check ups etc, and of more acute 
conditions like injury, sickness and suffering because of some condition. The general 
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health status of the population (H) is the basis from which the need for health care 
services is developed. Factors such as age, gender and SES-variables (X) can affect 
the need for health care services, indirectly by affecting the general health status, or 
directly if the need, given a certain health status, varies according to the factors. The 
need may lead to a demand for certain health care services, and in cases where the 
demand is greater than the supply, the consumption (F) will be restricted by the level 
of supply (T). Unmet need in this case arises if need does not create a demand, or if 
the demand is not met. The supply can affect the consumption of health care services 
not only by supplying less than is being demanded (restriction), but also by laying 
premises for the need. Preventive campaigns and medicine, screening and vaccination 
programs, healthy lifestyle advises and other early treatments offered to the 
population can both increase and decrease the need for health care services. In 
addition, the need may vary with a changing incidence/prevalence of diseases. The 
demand may vary with the conditions being treated or not, the consumers information 
about patient rights and possible treatment methods. The consumption of services 
may be affected by defensive medicine (over treatment) and different thresholds for 
offering treatment. 
The demand for health care services is placed as a variable between need and 
consumption in the following simplified way: 
Need = Demand, if no restrictions in the supply 
Demand = Consumption, if the supply > the demand 
This means that in cases with no restrictions in the supply, the need can be observed 
through the consumption (NOU 2008:2 2008). Unfortunately, using consumption as a 
measure of need does not incorporate the fact that: 
 the consumers of health care services may not be the ones in most need of the 
services 
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 there may be population groups which systematically under- or over consume 
health care services when compared to their need 
In situations like these, the hidden needs of the population results in a gap between 
the need and the consumption. 
Epidemiological data, on the other hand, gives a description of the health status and 
illness of the population independent of the consumption of health care services, and 
thus gives a more precise description of need. Epidemiological data is often collected 
in the form of national or regional health surveys, either through interviews or most 
usually through self-reporting/self-completing (questionnaires). The following factors 
may distort the results from surveys relying on interviews and self-reporting/self-
completing: 
 Selection/sampling bias: The selection of participants does not represent the 
population. Different/low response rates for different population groups may 
lead to a result that is not representative for the whole population. 
 Intervention bias: Different treatment of study groups. The interviewer may 
influence the respondent’s answers so that the answers are biased by the 
interviewer. 
 Measurement bias: Recall bias or reporting bias occurs when the respondent’s 
answers are affected by the memory of the respondent. 
(Peat et al. 2002) 
There may also be a varying understanding of the occurrence of a condition from one 
place to another and the way conditions are measured can also be influenced by 
cultural and geographical variation.  
Medical registers are another source of epidemiological data. The registers contain 
data gathered from small areas or patient groups, such as “Kreftregisteret” (the 
Cancer Registry of Norway). As there are no such register over heart diseases in 
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Norway (The Royal Norwegian Ministry of Health and Care Services submitted in 
the beginning of 2009 a matter of establishing a national register of heart diseases), 
using a registry is no alternative for this study. 
Considering these options, the use of consumption data from HTs for the analysis 
purposes stated in this investigation, seems most fitted. The results from the analysis 
have to be controlled for the population’s need for such treatment. Precise data on the 
need, measured as the incidence of AMI in the population, is not available because 
the data has to include both hospitalised patients and those not hospitalised. Using 
consumption data from hospitals as an indicator of need does not incorporate those 
cases not registered at a hospital. Epidemiological data on the prevalence of 
cardiovascular disease for the whole population of Norway is not available on 
municipality/county level. Similar studies (Ben-Shlomo and Chaturvedi 1995;Gatrell, 
Lancaster, Chapple, Horsley, & Smith 2002) use mortality data for ischemic heart 
disease (IHD) as a proxy measure of “need”. Using mortality as a proxy measure of 
incidence may lead to problems if the coding and diagnosis of death is not accurate. 
Also, mortality from IHD includes not only AMI (ICD-10 code I21 – I22), but also 
other diagnoses (ICD-10 code I20 – I25). For less acute diagnoses, referral thresholds 
and waiting times may have an impact on the mortality data. Furthermore, mortality 
data does not give information about how many AMI-patients that did not die 
because of correct and life saving treatment. Because of these problems with finding 
a precise measure of need for PCI-treatment, mortality data on IHD is included in the 
analysis as a separate variable which is analysed for its effect on the probability of 
getting PCI-treatment. At the same time the estimates for the other variables are 
controlled for need. If the probability of getting PCI is high in geographical areas 
where the mortality is high, and lower in areas where mortality is lower, there might 
be evidence of supply of health care services according to need. 
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3.4 Need/demand side independent variables 
3.4.1 Age 
Elderly patients are especially in the risk group for AMI. The mean age for AMI in 
the period of analysis is 70 years. Age is also a factor influencing the distribution of 
PCI. Traditionally, PCI is given in less extent to older patients (80 years and older). 
However, cardiologists say that nowadays “…a more liberal referral rate of elderly 
patients to invasive cardiac treatment has to be assumed” (Kristiansen 2003). Also 
acute medical treatment for AMI (thrombolytic treatment) is in less extent given to 
older patients (Jortveit & Brunvand 2006). Reasons for giving less treatment to older 
patients may be doubts about the utility value from the treatment and/or a higher risk 
for complications. 
This analysis investigates both the effect age have on the individual probability of 
getting PCI-treatment, and the effect the municipality age structure have on the 
probability of getting PCI for a patient living in a certain municipality. 
Individual age effect 
Investigating the effect age has on the individual probability of getting PCI is 
expected to show an increasing probability with age until a certain old age where the 
probability starts decreasing as a result of less PCI-treatment given to the very old 
patients. This effect is captured by two variables; a linear variable “Age” and a 
quadratic variable (Age)2.  
Municipality age structure effect 
Evidence for decreasing consumption of health care services with increasing waiting 
lists in municipalities (Nerland & Hagen 2008), implies inequality. Patients living in 
areas where the demand for a certain health care service is relatively high compared 
with the actual supply of the service (supply side restrictions) tend to consume less 
than what is needed or demanded. The majority of new AMIs occur in the age group 
60 – 90 years (Hagen & Reikvam 2003). Since age is one of the major risk factors for 
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AMI, one may assume that areas with a relatively large population in age groups with 
elevated risk for AMI, experience a higher ratio of AMIs per 100 000 population than 
other areas. 
This study investigates whether there is evidence of lower probability of PCI in areas 
where the share of older patients is relatively high. Different age groups are included 
in the regression analysis as independent variables and are analysed for their effect on 
the probability of PCI for a patient living in a given municipality. The number of 
people in the age groups “45 to 66 years old”, “67 to 79 years old” and “80 years and 
older” are found for each municipality for each year of the analysis. The share of the 
municipality population in these groups are calculated and included in the analysis. 
Younger age groups are excluded from the analysis because AMI is a diagnosis most 
common in older age groups (see chapter 2.1). 
It is expected that the probability of getting PCI is low in municipalities having a 
large share of the citizens in the age risk groups for AMI. However, results showing 
the opposite effect would imply a better supply of PCI-treatment in these 
municipalities than in others. Such evidence would imply that relative differences in 
need are reflected by the same relative differences in supply and consumption. 
3.4.2 Gender 
Cardiovascular diseases (for definition see chapter 1.1) are the number one death 
cause for Norwegian women. Cancer is the second most deadly disease. Historically, 
middle aged and older men with unhealthy lifestyles have been the main risk group 
for cardiovascular diseases, but the gap between men and women is decreasing. 
Figure 3.2 shows historic mortality numbers from IHD (ICD-10 code I20 – I25) for 
males and females6. 
                                              
6 Mortality numbers from AMI for males and females are not available, mortality numbers from IHD is therefore used in 
stead. IHD (ICD-10 code I20 – I25) includes AMI (ICD-10 code I21 – I22). 
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Figure 3.2 Mortality from IHD per 100 000, 1951 – 2003. 
(Dødsårsaksregisteret 2009). 
Risk factors, symptoms and types of heart diseases can differ from men to women. 
Diagnosing women is often more difficult because of diffuse symptoms, additional 
diseases (elevated blood pressure and diabetes) and a higher age (Krüger 2007). Men 
are more likely to develop a stenosis (narrowing) in the coronary artery, which in 
many cases can be treated with PCI. Women often experience a more diffuse disease 
in the artery walls with cholesterol laden plaques gathering without causing a 
stenosis. In cases like these, PCI is no longer the best treatment method. When AMI 
is diagnosed women more often than men die or experience a heart failure after the 
AMI (LHL 2009). Because of the different symptoms and diffuse disease characters 
women often experience, the actual need for PCI-treatment for women is difficult to 
estimate. Kristiansen (Kristiansen 2003) found that men have 200 – 400 % higher 
rate of intervention (CABG, PCI) than women. A more diffuse disease character 
combined with other treatment methods, may contribute to some of the differences. 
Gatrell (Gatrell, Lancaster, Chapple, Horsley, & Smith 2002;Kristiansen 2003) also 
found that PCI treatment are given in less extent to women. The study is controlled 
for need, which is measured by mortality from ischemic heart disease (see discussion 
of mortality as a proxy for need in chapter 3.3). 
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Gender is included as an independent variable in the regression analysis to estimate 
the different probability of getting PCI for males (value 1) and females (value 2). The 
estimate is expected to show a lower probability for women getting PCI. 
3.4.3 SES 
Health status is a result of heredity (genes, diseases etc.), environment (pollution, 
housing, hygiene etc.) and lifestyle (smoking, alcohol, physical activity, nutrition, 
stress, sleep etc.). Evidence from many different countries has| established a link 
between low SES and poor health, as SES especially affects the environment and 
lifestyle of the individuals. Consumption of health care services however, may help 
improving the health status either by preventive help or by immediate help. The 
question is whether individuals with low SES achieve the health care services they 
need or not. Studies investigating the effect of SES-variables on consumption of 
health care services have found evidence of underconsumption for people from low 
SES (Ben-Shlomo & Chaturvedi 1995;Manson-Siddle & Robinson 1998). Measures 
or variables that indicate the SES of individuals or groups most often include 
education, income and occupation (unemployed, disabled, type of work) (Carlsen 
2006;Nasjonalt folkehelseinstitutt 2007a;NOU 2008:2 2008). 
Municipality education level effect 
In Norway during the 1990s, the life expectation for men ranged from 71,8 years for 
those with only junior high school to 76,7 years for those with a university degree. 
For women, the same range was from 78,0 years to 81,4 years. The link between 
education and mortality may come from unobserved factors such as for instance 
cognitive ability. Cognitive ability may lead to good health and better education. 
Education may improve health related knowledge and thereby initiate healthier life 
styles, which again reduce the mortality risk. As an important determinant of 
occupational career, education may lead to a high and stable position in the labour 
market. A high work position constitutes a continuous opportunity for ensuring high 
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income and favourable living conditions, which again may lead to better health status 
(Strand and Kunst 2007). 
A high education level is assumed to influence the purchasing power of health care 
services upwards, as people’s education influence their life style and health 
consciousness. Municipality data for each year on the share of the municipality 
population having only lower education (primary school/junior high school) is 
included in the regression analysis as an independent variable to estimate the effect 
education has on the probability of PCI. A low education level in a municipality is 
assumed to have a negative effect on the probability of getting PCI for the citizens of 
the municipality.  
Effect of personal income, municipality level 
A link between low income and poor health has also been established. In Norway in 
the period 1994 – 2003 those with low income had higher mortality rates than those 
with high income. For women, the differences between low and high income groups 
increased in the period 1994 – 2003. The differences for men in the same period were 
unchanged (Nasjonalt folkehelseinstitutt 2007b).  
Education and income are assumed to have the same effect on the purchasing power 
of health care services, life style and health consciousness. Municipality data per year 
on mean income for the inhabitants is gathered and included in the regression 
analysis (see chapter 4.8.1 for test for multicollinearity). Data from 2007 is not 
available (see chapter 4.5 for description of extrapolation). The income is converted 
to 2007 NOK level. A high income is assumed to influence the purchasing power of 
health care services upwards, as people’s income may influence their life style and 
health consciousness. A low mean municipality income is assumed to have a negative 
effect on the probability of getting PCI for the citizens of the municipality.  
Municipality unemployment effect 
Involuntarily loss of salaried work represents a complex psychosocial load as a result 
of a weakened social network, loss of identity and lowered self respect. The most 
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common health problems resulting from unemployment are depression and anxiety. 
Somatic diseases resulting from unemployment are less common than psychological 
diseases, but there is evidence of the unemployed consuming more health care 
services, medicaments and intoxicating substances than others. The unemployed also 
have higher mortality rates (Nylenna 2009). 
The share of unemployed per municipality per year is included as an independent 
variable in the regression analysis to estimate the effect of unemployment. A high 
share of unemployed is assumed to have a negative effect on the probability of PCI. 
Municipality disability effect 
Similarly, a link between disability and a corresponding lowered health status seems 
possible. Carlsen (Carlsen 2006) found that a higher number of disabled are 
correlated with a higher consumption of health care services, indicating a lower 
health status amongst the disabled. 
The share of disabled per municipality per year is included as an independent variable 
in the regression analysis to estimate the effect of disability. A high share of disabled 
is assumed to have a negative effect on the probability of PCI. 
3.4.4 Mortality from IHD 
Several studies use mortality data on IHD as a proxy measure of incidence to 
overcome the problem of estimating the exact need for treatment. They do this by 
comparing the variations in procedure rates with variations in mortality rates (see 
chapter 3.3). Since mortality data include patients dying also outside hospitals, the 
coding of the cause of death is likely to be less accurate. Because mortality data is a 
proxy measure of the community incidence rather than the hospital incidence, these 
data gives information which the NPR-data do not contain. 
This study therefore uses AMI admissions to hospitals and the crude numbers of PCI-
treatment as data on actual consumption. Mortality data is included in the regression 
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analysis to control the results based on actual consumption with the community 
incidence (need). 
Mortality data on IHD for the counties per year in Norway is included in the analysis 
as an independent variable which is analysed for its effect on the probability of PCI. 
The number of deaths per 100 000 population per county is used as a measure of the 
need for PCI-treatment. If the probability of getting PCI is high in geographical areas 
where the mortality is high, and lower in areas where mortality is lower, there might 
be evidence of relative differences in need being reflected by the same relative 
differences in supply and consumption. 
3.5 Supply side independent variables 
3.5.1 Travel distance 
In studies of general consumption and access to health care services in Norway 
(Nerland & Hagen 2008) the effect of the distance to treatment centre is negative, 
meaning that the consumption of health care services decreases with an increase in 
the travel distance to hospital. Especially emergency and out-patient treatments are 
affected by the distance from the patients’ home municipality to the nearest hospital. 
Following this, the distance to PCI-treatment centre is included in the analysis. Table 
3.1 shows the HTs offering PCI-treatment and their geographical location 
(municipality). 
The catchment areas to the PCI-centres for the years 1999 – 2002 are outlined in 
Figure 3.3. 
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Figure 3.3 Catchment areas for PCI-centres, 1999 – 2002. 
The establishment of a PCI-centre in Arendal in 2003 changed the catchment area of 
the PCI-centres in South (South-East) Norway RHA. The new catchment areas for 
the years 2003 – 2007 are implemented in the analysis and are outlined in Figure 3.4. 
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Figure 3.4 Catchment areas for PCI-centres in South (South-East) RHA, 
2003 – 2007. 
 
The guidelines describing which hospital the patients are to be treated at for the 
different RHAs are followed in the analysis with the following 
simplification/adjustment: 
 The West Norway RHA operates with different catchment areas due to 
helicopter weather and day, or day-and-night services at the different hospitals 
offering PCI treatment. In the analysis this is not taken into account because of 
the complications this will lead to in the analysis. The catchment areas are 
stated as if the hospitals are open at all times and that there are always 
helicopter weather, see Table 3.4. 
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Table 3.4 Catchment areas for the hospitals offering PCI treatment in West 
Norway RHA used in the analysis. 
Hospital Catchment area 
Stavanger Universitetssykehus HT All municipalities within Rogaland county 
Haukeland Universitetssykehus HT 
All municipalities within Hordaland and Sogn og 
Fjordane counties 
 
The distance in overhead line in km from the centre of each municipality to the centre 
of the municipality with a HT giving PCI-treatment is included in the analysis as an 
independent variable. According to medical guidelines (see chapter 2.4) patients 
living far from PCI-treatment centre are in many cases administered thrombolytic 
therapy instead of PCI-treatment. It is therefore expected to find evidence for a 
negative effect of the distance, meaning that with increasing distance to PCI-
treatment centre there are decreasing probability of PCI. 
3.5.2 HT and year dummy variables (fixed effects) 
As shown in Figure 3.1 the consumption rate can be influenced or restricted by the 
supply and availability of health care services. As long as the demand for treatment is 
larger than the supply, supply side differences will affect the consumption rates. 
Access to resources, efficiency, organising and leadership are typical supply side 
factors that may differ between the HTs and between the RHAs because of different 
organising, geographical adjustments, patient mix etc. Differences in these factors 
may lead to different supply side effects between the HTs. 
The danger of erroneous inference due to supply side effects is most present when the 
level of a consumption analysis coincides with the level of the supply side. Analyses 
of aggregated consumption rates per HT would to a large extent coincide with the 
county of residence for the patients and the HT treatment area, and such analyses are 
thus in danger of getting results influenced by unwanted supply side effects. The 
supply side effects, in this study the supply side effects from the HTs in the 
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secondary care services, are handled both by bringing the analyses down to a lower 
level than the level of the HTs and by including HT dummies. Using small-areas 
(municipalities) or individuals as the level of analysis give a larger number of 
observations and more precise estimates of the variables, and in addition reduce the 
danger of level fallacy (Smith 2007).  
The analysis of consumption of PCI-treatment is executed at individual level. The 
estimates are presented at both individual, municipality, county and HT-level. 
Hierarchic aggregation of the results is used to aggregate the data from individual 
level and up to higher levels (municipality, county, HT). This enables the estimates at 
higher levels to explain variations at lower levels. In this way, hierarchic aggregation 
reduces unwanted supply side effects from the HTs and at the same time enables 
comparisons at HT level. 
Possible supply side differences between the HTs are also tried avoided in the 
analysis by excluding the variation between the HTs and using the variation between 
consumption and the need variables within the HTs to calculate the estimates. This is 
done by including HT dummies (HTNR1 – HTNR24) which captured the effect of 
unequal supply side effects between the HTs. (NOU 2008:2 2008). HTNR = 24 is 
used as reference unit, table 7.1 in the appendix gives an overview over the HTs. 
Investigating the change in probability of PCI across the years is done in a similar 
way by including dummies for years (T1999 – T2007), with year = 2007 as reference 
unit. 
3.6 Summary 
Chapter 3 describes both the institutional and the financial framework laying 
premises for equal supply and access to PCI-treatment for all patients in Norway. The 
need/demand side variables and the supply side variables included in the analysis and 
investigated for their influence on the dependent variable, the probability of PCI, are 
also described. The need/demand side variables include both individual variables and 
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municipality variables. The individual variables age and gender are expected to affect 
the probability of getting PCI in favour of middle aged men, disfavouring women and 
very old persons. Municipality variables indicating low SES (low education level, 
low income, high share of unemployed and high share of disabled) are expected to 
have a negative impact on the consumption rate and probability of getting PCI for 
AMI. Such results would indicate inequalities in the probability of PCI. The results 
are controlled for need, measured as mortality from IHD per 100 000 population per 
county. The supply side variables include travel distance to PCI-treatment per 
municipality, which is expected to have a negative estimate, and HT dummies which 
are included in the analysis to avoid that the estimates are influenced by supply side 
differences between the HTs. Table 3.5 defines and sums up the independent 
variables included in the analysis. 
Table 3.5 Definition of independent variables 
Variable Definition 
Age From NPR-data: individual age on AMI-patients 
(Age)2 Age * Age 
Gender From NPR-data: individual gender on AMI-patients 
Share 45 - 66 Number of citizens 45 - 66 years/number of citizens 
Share 67 - 79 Number of citizens 67 - 79 years/number of citizens 
Share 80+ Number of citizens 80 years and above/number of citizens 
Distance PCI Distance from home municipality to PCI-treatment centre 
Share disabled Number of disabled/number of citizens 
Mean income Sum personal income for all citizens/number of citizens 
Share low education Number of citizens with low education/number of citizens 
Share unemployed Number of unemployed/number of citizens 
Mortality IHD Number of deaths from IHD per 100 000 population 
HTNR HTNR24=dummy (value=0) 
T T2007=dummy (value=0) 
 
The institutional set up, the financing of the RHAs and the estimates for the 
independent variables are the background for insight and answers to the research 
questions presented in chapter 1: 
1) Is there significant evidence for unequal access, measured as varying 
probability of PCI, in Norway in the period of analysis? 
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2) Is there significant evidence for an unequal probability of PCI between those 
patients living in the catchment area of HTs with PCI-treatment and those 
living in the catchment area of HTs without PCI-treatment? 
3) Is there significant evidence for an unequal probability of PCI within the 
group of HTs with PCI?  
4) Is there significant evidence for an unequal probability of PCI within the 
group of HTs without PCI?  
5) Are demographical variables, SES-variables and geographical location 
independently associated with the probability of PCI? 
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4. Data and method 
4.1 Ethical considerations 
The study has been ethically reviewed and approved by “Personvernombudet for 
forskning”, “Regional komité for medisinsk og helsefaglig forskningsetikk Sør-Øst 
(REK Sør-Øst)” and ”Helsedirektoratet (Norwegian Directorate of Health)” to ensure 
that personal information protection, ethical guidelines and obligations to maintain 
secrecies are followed and that the research are done in accordance with the law. 
4.2 NPR-data 
Chapter 2 describes the medical aspects of AMI, treatment alternatives and the 
medical guidelines for the treatment alternatives. Figure 2.1 and Figure 2.2 show the 
number of reported AMIs during the period of analysis in crude number and per 
100 000 population. The basis for these numbers is NPR-data for the years 1999 – 
2007 which represents a register over all HT admissions in the given period of time. 
Using NPR-data for analysis purposes require knowledge about how the data came in 
to being, its contents and certain limitations connected to the data material. 
Each HT registers all admissions in a system where each patient is assigned a patient 
number from a number series administered by the hospital. Information about the 
patient is registered on the patient number: personal number, name, gender, address, 
home municipality, diagnosis, treatment, length of stay and so on. Different coding 
practice for the same diagnose and treatment lower the quality of the data. This is not 
very likely to be the case for AMI (see chapter 6.4 for discussion about this). Every 
tertian the HTs report these data over admissions and hospital activity to NPR. 
Because of laws restricting the use of personal identification until recently 
(Fornyings- og administrasjonsdepartementet 2009;Helse- og omsorgsdepartementet 
2009a;Justis- og politidepartementet 2009), the data stored and made available from 
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NPR used in this study is without personal identification information. Without 
personal identification, a patient who visits several hospitals can not be identified by 
the NPR-data. The NPR-data contains number of hospital admissions/stays, 
independent of the actual number of patients. 
As described in chapter 3.5.1, not all hospitals offer PCI-treatment. A patient 
experiencing AMI will in some cases be sent directly to a hospital offering PCI-
treatment, in other cases to a hospital not offering PCI-treatment. If the investigation 
of the patient reveals the need for PCI-treatment, the patient admitted to a hospital 
without PCI-treatment is sent further on to a hospital offering PCI-treatment. After 
the invasive surgery (PCI-treatment), some patients may experience being sent back 
to the local hospital for recovery instead of staying at the HT with PCI-treatment. 
Regarding the registered admissions in the case where the patient has to be referred to 
another hospital for PCI-treatment, one AMI case generates two, possible three, AMI 
admissions and one PCI-treatment. If the initial hospital had offered PCI treatment, 
the registered admissions would have shown one AMI admission and one PCI-
treatment. Thus, the probability of getting PCI-treatment, calculated as the number of 
PCIs divided on the number of AMIs, for municipalities within the catchment area of 
a hospital not offering PCI-treatment may show a false low rate because of a higher 
AMI number than is the case. This is a problem following the use of NPR-data and if 
possible should be corrected for. The use of HT dummies in this analysis corrects for 
some of this variation between the HTs, but still the results should be interpreted 
carefully with this problem in mind. 
4.3 Dependent variable: Probability of PCI 
Before the dependent variable is calculated from the NPR-data, all AMI admissions 
coded with an age less than 15 years are excluded from the data used in the analysis. 
Because AMI very rarely occur at young age, the admissions coded with an age less 
than 15 are most likely results of code error or other registration error. The number of 
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excluded admissions because of code/registration error is insignificant for the results 
of the analysis. 
The descriptive statistics for the dependent variable, probability of PCI, shows an 
increasing trend for the whole of Norway during the period of analysis 1999 – 2007, 
see Table 4.1. In 1999 only 3% of the AMI admissions are treated with PCI. In 2007 
24% of all AMI admissions are treated with PCI. The probabilities differ greatly 
between the HTs, both between the HTs with PCI-treatment and between the HTs 
without PCI treatment, see chapter 5. 
4.4 Other data sources 
Individual variables describing age and gender of the patients are gathered from the 
NPR-data. The variables describing municipality age structure, number of persons 
with low education level, gross mean income, number of unemployed and number of 
disabled persons are gathered from Statistics Norway (SSB) and Norwegian Social 
Science Data Services (NSD) and are only available at municipality level. County 
mortality data for IHD is gathered from Statistics Norway (SSB) for the period 1999 - 
2006. Data from 2007 is not available (see chapter 4.5 for description of 
extrapolation). The data is only available on county level because of patient safety 
concerns connected to the data. The matrix over the distances in kilometres from each 
municipality centre to the centre of the hospital municipality is prepared and 
calculated by InfoMap Norge AS  (Iversen & Kopperud 2002b;Kopperud 2002). 
4.5 Extrapolation: centered moving average 
The variables “Mortality IHD” and “Mean income” are extrapolated to fill in missing 
values for the year 2007. This is done in SAS (Statistical Analysis System) by using 
PROC EXPAND and CMOVAVE statements. PROC EXPAND replaces missing 
values at the beginning or at the end of input series (SAS Institute Inc. 2009). 
CMOVAVE means centered moving average and can be referred to as a “smoothing 
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technique” designed to reduce or eliminate short-term instability in the data. A 
smoothed series is preferred to a non-smoothed one because it may capture changes 
in the underlying trend instead of capturing insignificant changes due to for instance 
one special measurement varying from the others. 
Centered moving average consolidates the yearly data points of “Mortality IHD” and 
“Mean income” into longer units of time so that an average of several years is created 
based on the middle value of the data and thus gives a value for the year 2007 based 
on the average of several year’s data. The downside by using this technique is that 
some of the variable’s timeliness is lost. For this reason, a “weighted” moving 
average is used in this analysis, putting more importance on the more current values 
(the last three years) (Federal Reserve Bank of Dallas 2009). The extrapolated values 
for the years 1999 – 2007 are used in stead of the real values for the years 1999 – 
2006 and the extrapolated value for 2007. 
4.6 Statistical analysis tool 
Performing the regression analysis with several variables (municipalities, age groups, 
individual age and gender, SES-variables, distances to treatment centre, HF and year 
dummies) on the NPR-data consisting of 147 396 admissions is done with SAS. SAS 
enables analyses of large amounts of data and handles dummy variables in a good 
way. The drawback is the complexity of the system and the need for a person with 
programming skills within SAS. 
4.7 Empirical model 
The study is designed as a pooled cross-sectional study. This is the same as repeated 
cross-sectional, or trend design. A “cross-section” – a slice that cuts across an entire 
population – is used to see all parts, or sections, of that population. In a pooled cross-
sectional study, the data is collected over time so that the relationship between cause 
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(independent variables) and effect (dependent variable) can be investigated 
(Chambliss and Schutt 2006). 
The basic empirical model should capture the effects the independent variables have 
on the probability of PCI (dependent variable). The need/demand side variables 
include individual patient specific variables, municipality specific variables and a 
county specific variable. The supply side variables include a municipality specific 
variable and a HT specific variable. The multiple linear regression model where the 
probability of getting PCI for patient i in municipality j and county k per year is given 
by 
ijkjkjiijijk eDxxxxxY  655443322110      (1) 
where footprint for year t  is suppressed. 0  is a constant term, x denotes patient is 
age and also the three age groups at municipality level included in the analysis.  
denotes patient is gender, value 1 assigned male patients, value 2 assigned female 
patients. Independent variables taking only two values are called dummy variables 
and in most cases the values 0 and 1 are assigned the variables (Newbold et al. 2006). 
The values assigned (1 and 2, instead of 0 and 1) affect the intercept by moving the 
intercept along the x-axis from the x value = 0 (men) to the x value = 1 (men) so that 
a new intercept is created. The regression line stays the same (the regression 
estimates are not affected) and thus for the purpose of this analysis, it does not matter 
whether values 0 and 1, or values 1 and 2 are used. Male, value 1, is defined as the 
reference unit with the estimate for gender defining the difference female patients 
have on the probability of PCI compared with male patients.  denotes SES-
variables at municipality level,  denotes mortality from IHD at county level and 
 denotes travel distance to PCI-treatment centre at municipality level.  is the 
error term for all levels. D is a vector for hospital trust specific (H) and year specific 
(T) dummy variables. Equation (2) expresses this alternative specification for the 
dummies in (1) 
ij1
ix2
jx3
kx4
jx5 ijke
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THD 87             (2) 
The hospital trust specific H and year specific T dummy variables work as “fixed 
effects”. The estimate of the impact of HTNR24 (hospital area number 24) is 
assigned the reference value 0. The estimate of the impact of year 2007 is also 
assigned the reference value 0. The estimates for the other H and T dummies show if 
there are significant differences between the different HTs and years compared to the 
reference values. The fixed effects capture both observed and unobserved time-
constant variables. Additionally, the control for fixed effects make it possible to study 
the within effects of the time-varying variables, for example SES-variables 
(Martinussen and Hagen 2009). The estimates of the SES-variable “Share low 
education” tell how much “Prob PCI” changes as “Share low education” changes, 
within the specific HTs. 
4.8 Assumptions 
4.8.1 Statistical 
The population sample used in this study – pooled cross-sectional population sample 
(NPR-data from 1999 - 2007) – ensures that the generalisability is good and that the 
results are applicable to similar populations. The relatively large sample size 
(147 396 patients with AMI) ensures that the probability of type I and type II errors 
are minimized. The power is adequate to show significant results and the estimates 
are likely to be precise. The validity of the instrument (multiple regression) and the 
accuracy of the results are dependent on the data quality, which is considered to be 
good. 
The independent variables are tested for normality and as anticipated, all of them are 
normally distributed. The error term is assumed to have a normal distribution. 
The standard assumptions for multiple regressions (homoscedasticity, 
heteroscedasticity and multicollinearity) (Newbold, Carlson, & Thorne 2006) are 
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checked and the only assumption not fulfilled is the requirement of no linear 
relationship between two of the explanatory variables (multicollinearity). The 
procedure CORR in SAS is used to compute Pearson product-moment correlation on 
the independent variables. Pearson correlation is a parametric measure of a linear 
relationship between two variables (SAS Institute Inc. 2009) which if being 
correlated, may disturb the results of the main analysis. The variable “Low education 
level” is strongly correlated with “Mean income” (Pearson correlation of -0,77) and 
having to choose which one of the variables to keep in the analysis, “Mean income” 
is excluded and “Low education level” is kept due to the stronger explanatory power 
of this variable. Also, studies argue for the level of education as an explanatory factor 
for health status and survival from diseases in comparison with the average income 
(Kravdal 2006;Lovasi et al. 2008;NOU 2008:2 2008). 
Significant explanatory variables not included in the analysis are a general problem 
for regression analyses. In this study local variables explaining AMI incidence or PCI 
demand, may be examples of such variables. The fixed effects included in this 
analysis (HT-dummies and year-dummies) capture most of the effect of potential 
variables not included, but probably not all effects. 
4.8.2 Methodical 
To simplify the analysis, the assumption that patients always are within their home 
municipality when having an AMI, is set. This is done because the distance between 
home municipality and HT with PCI-treatment is included in the analysis as an 
independent variable. Thus, if patients to a large extent are not within their home 
municipality when having AMI (work, vacation etc.) the distance variable looses its 
explanatory power. 
PCI treatment of AMI is assumed always to be executed as emergency treatment, not 
as an elective treatment. Thus, the free choice of hospital is eliminated as an 
unwanted effect on the distance variable. CABG-treatment was initially considered 
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included in the analysis but since this treatment to a large extent is given elective, this 
treatment is excluded from the analysis. 
4.9 Descriptive statistics 
Descriptive statistics for the variables included in the analysis are presented in Table 
4.1. The variable “ProbPCI” shows the percentage probability of PCI, calculated 
from number of PCI divided on number of AMI (NPR-data). The variables “Age”, 
“(Age)2“ and “Gender” show values calculated on the basis of the AMI admissions 
(NPR-data). The age variables are given in years. The gender variable assigns the 
value 1 to male and 2 to females. The variables describing share of age groups and 
SES show the calculated values of their percentage share of the population per 
municipality. The variable “Mortality IHD” are given in number of deaths per 
100 000 population per county. The variable “Distance PCI” is given in km. 
Table 4.1 Descriptive statistics of variables, 1999 – 2007. 
  Mean Std Dev Minimum Maximum 
1999 (Valid N=11771)         
ProbPCI 0,03 0,17 0,00 1,00
Age (AMI) 70,97 13,18 18,00 103,00
(Age)2 (AMI) 5210,16 1775,92 324,00 10609,00
Gender (AMI) (2=female) 1,37 0,48 1,00 2,00
Share 45 - 66 0,24 0,02 0,18 0,33
Share 67 - 79 0,10 0,02 0,05 0,18
Share 80+ 0,04 0,01 0,02 0,12
Share low education 0,28 0,06 0,14 0,53
Share unemployed 0,01 0,00 0,00 0,05
Share disabled 0,06 0,02 0,02 0,14
Mortality IHD 192,89 31,20 133,08 244,33
Distance PCI (km) 142,56 170,02 0,00 1017,90
     
2000 (Valid N=11776)         
ProbPCI 0,05 0,22 0,00 1,00
Age (AMI) 70,76 13,45 19,00 100,00
(Age)2 (AMI) 5187,29 1809,71 361,00 10000,00
Gender (AMI) (2=female) 1,37 0,48 1,00 2,00
Share 45 - 66 0,25 0,02 0,19 0,32
Share 67 - 79 0,10 0,02 0,05 0,18
Share 80+ 0,04 0,01 0,02 0,12
Share low education 0,27 0,06 0,14 0,54
Share unemployed 0,01 0,00 0,00 0,06
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Share disabled 0,06 0,02 0,03 0,14
Mortality IHD 188,37 30,96 131,41 241,43
Distance PCI (km) 143,89 172,38 0,00 1017,90
     
2001 (Valid N=14617)         
ProbPCI 0,08 0,27 0,00 1,00
Age (AMI) 71,19 13,62 20,00 107,00
(Age)2 (AMI) 5253,47 1839,57 400,00 11449,00
Gender (AMI) (2=female) 1,37 0,48 1,00 2,00
Share 45 - 66 0,25 0,02 0,19 0,32
Share 67 - 79 0,10 0,02 0,05 0,17
Share 80+ 0,05 0,01 0,02 0,12
Share low education 0,27 0,05 0,14 0,52
Share unemployed 0,01 0,00 0,00 0,05
Share disabled 0,07 0,39 0,03 43,12
Mortality IHD 180,61 29,77 127,94 234,08
Distance PCI (km) 144,63 166,95 0,00 1017,90
     
2002 (Valid N=15626)         
ProbPCI 0,13 0,33 0,00 1,00
Age (AMI) 70,97 13,89 19,00 104,00
(Age)2 (AMI) 5229,56 1888,13 361,00 10816,00
Gender (AMI) (2=female) 1,37 0,48 1,00 2,00
Share 45 - 66 0,25 0,02 0,20 0,33
Share 67 - 79 0,09 0,02 0,05 0,16
Share 80+ 0,05 0,01 0,02 0,12
Share low education 0,26 0,05 0,14 0,52
Share unemployed 0,05 0,01 0,03 0,11
Share disabled 0,07 0,51 0,03 42,93
Mortality IHD 174,46 30,27 120,41 234,21
Distance PCI (km) 140,64 164,06 0,00 1017,90
     
2003 (Valid N=17844)         
ProbPCI 0,17 0,37 0,00 1,00
Age (AMI) 70,55 14,05 18,00 103,00
(Age)2 (AMI) 5175,13 1899,69 324,00 10609,00
Gender (AMI) (2=female) 1,38 0,48 1,00 2,00
Share 45 - 66 0,26 0,02 0,20 0,33
Share 67 - 79 0,09 0,02 0,05 0,17
Share 80+ 0,05 0,01 0,02 0,13
Share low education 0,26 0,05 0,14 0,50
Share unemployed 0,02 0,01 0,01 0,07
Share disabled 0,07 0,49 0,03 44,66
Mortality IHD 165,34 28,87 114,00 224,71
Distance PCI (km) 129,90 162,39 0,00 1017,90
     
2004 (Valid N=18141)         
ProbPCI 0,20 0,40 0,00 1,00
Age (AMI) 70,49 13,98 19,00 104,00
(Age)2 (AMI) 5164,11 1898,45 361,00 10816,00
Gender (AMI) (2=female) 1,36 0,48 1,00 2,00
Share 45 - 66 0,26 0,02 0,20 0,34
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Share 67 - 79 0,09 0,02 0,05 0,16
Share 80+ 0,05 0,01 0,02 0,14
Share low education 0,26 0,05 0,14 0,48
Share unemployed 0,02 0,01 0,01 0,06
Share disabled 0,07 0,26 0,03 21,97
Mortality IHD 150,98 26,87 104,00 204,61
Distance PCI (km) 128,66 162,69 0,00 1017,90
     
2005 (Valid N=18570)         
ProbPCI 0,22 0,42 0,00 1,00
Age (AMI) 70,05 13,91 18,00 103,00
(Age)2 (AMI) 5100,36 1890,77 324,00 10609,00
Gender (AMI) (2=female) 1,35 0,48 1,00 2,00
Share 45 - 66 0,27 0,02 0,21 0,35
Share 67 - 79 0,09 0,02 0,05 0,16
Share 80+ 0,05 0,01 0,02 0,12
Share low education 0,25 0,05 0,14 0,49
Share unemployed 0,02 0,01 0,00 0,05
Share disabled 0,08 0,54 0,03 22,56
Mortality IHD 139,14 23,91 97,20 179,89
Distance PCI (km) 132,60 165,06 0,00 1017,90
     
2006 (Valid N=19561)         
ProbPCI 0,24 0,43 0,00 1,00
Age (AMI) 69,66 14,23 18,00 107,00
(Age)2 (AMI) 5054,40 1923,35 324,00 11449,00
Gender (AMI) (2=female) 1,35 0,48 1,00 2,00
Share 45 - 66 0,27 0,02 0,22 0,35
Share 67 - 79 0,09 0,02 0,04 0,16
Share 80+ 0,05 0,01 0,02 0,12
Share low education 0,25 0,05 0,14 0,48
Share unemployed 0,01 0,00 0,00 0,05
Share disabled 0,07 0,23 0,03 18,44
Mortality IHD 133,01 23,78 91,36 171,60
Distance PCI (km) 130,15 158,89 0,00 1017,90
     
2007 (Valid N=19490)         
ProbPCI 0,24 0,43 0,00 1,00
Age (AMI) 69,73 14,07 18,00 103,00
(Age)2 (AMI) 5060,59 1913,03 324,00 10609,00
Gender (AMI) (2=female) 1,34 0,47 1,00 2,00
Share 45 - 66 0,27 0,02 0,23 0,36
Share 67 - 79 0,09 0,02 0,04 0,16
Share 80+ 0,05 0,01 0,02 0,12
Share low education 0,25 0,05 0,14 0,50
Share unemployed 0,01 0,00 0,00 0,04
Share disabled 0,06 0,02 0,02 0,13
Mortality IHD 130,09 22,56 89,28 165,96
Distance PCI (km) 130,54 160,37 0,00 1017,90
Table 4.1 shows an increasing mean value for the probability of PCI from 1999 to 
2007. In 1999 only 3% of the AMI admissions are treated with PCI. In 2007 24% of 
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all AMI admissions are treated with PCI. The mean age of patients admitted with 
AMI is 70 years and has been steady in the period of analysis. When it comes to 
gender, about two thirds of the AMI patients are men. The mortality from IHD is 
steadily decreasing from a mean of 193 deaths per 100 000 population in 1999 to 130 
deaths in 2007. The mean distance to PCI-treatment centre is decreasing from a peak 
in 2001 at approximately 145 km, to approximately 130 km in 2006/2007. 
Table 4.2 shows descriptive statistics for AMI and PCI per 10-year age groups from 
60 years and above. Number of AMI-admissions per age group, number of PCI-
treatments per age group and the probability of PCI per age group are calculated from 
the NPR-data. 
Table 4.2 Descriptive statistics of AMI and PCI per 10-year age group, 
1999 – 2007. 
  1999 2000 2001 2002 2003 2004 2005 2006 2007
Age 60 - 
69                   
AMI 2113 2034 2526 2670 3127 3263 3891 4011 4190
PCI 97 138 304 498 759 899 1129 1265 1250
ProbPCI 5 % 7 % 12 % 19 % 24 % 28 % 29 % 32 % 30 %
Age 70 - 
79                   
AMI 3656 3477 4109 4114 4589 4602 4463 4568 4595
PCI 63 110 245 413 664 873 974 1097 1089
ProbPCI 2 % 3 % 6 % 10 % 14 % 19 % 22 % 24 % 24 %
Age 80 - 
89                   
AMI 3120 3164 4151 4389 4838 4830 4659 4862 4692
PCI 14 19 74 114 258 345 460 552 611
ProbPCI 0 % 1 % 2 % 3 % 5 % 7 % 10 % 11 % 13 %
Age 90 +                   
AMI 451 485 707 838 973 1027 1064 1066 1139
PCI 0 1 0 4 12 19 9 23 36
ProbPCI 0 % 0 % 0 % 0 % 1 % 2 % 1 % 2 % 3 %
 
A distinct treatment pattern showing a decreasing probability of PCI with higher age 
is evident. Figure 4.1 is a graphic representation of the probability of PCI per age 
group. The curves of the age groups 60 – 69 years and 70 – 79 years seem to slightly 
flatten off from 2006 to 2007, but whether this is a starting trend or only small 
adjustments are uncertain. 
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Figure 4.1 Probability of PCI per age group, 1999 – 2007. 
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5. Results 
Approximately 148 000 admissions are registered with AMI as main diagnosis 
between 1999 and 2007. Due to suspicion of errors in the coding of some of the 
admissions (age < 15 year) and because of missing data (municipality number), the 
data set used in the analysis consists of 147 396 AMI admissions. 
The basic model, equation (1), is estimated via multiple linear regression analysis, 
and the results are reported in Table 5.1. The regression estimates are then 
commented and applied in the answers to the research questions. Additional analyses 
on differences between and within the HTs with PCI-treatment centre and the HTs 
without PCI-treatment centre are carried out to answer some of the research 
questions. 
Table 5.1 Results obtained from the regression analysis, 1999 – 2007. 
Variable Estimate Standard error t-value p-value 
Intercept 0,0427 0,0357 1,2000 0,2315 
Age 0,0096 0,0006 16,9800 <,0001 
(Age)2 -0,0001 0,0000 -27,9700 <,0001 
Gender -0,0190 0,0020 -9,5700 <,0001 
Share 45 - 66 0,1020 0,0867 1,1800 0,2395 
Share 67 - 79 0,0910 0,1243 0,7300 0,4644 
Share 80+ -0,4682 0,1558 -3,0100 0,0027 
Distance PCI -0,0001 0,0000 -6,3500 <,0001 
Share disabled -0,0020 0,0026 -0,7600 0,4486 
Share low education -0,0025 0,0286 -0,0900 0,9315 
Share unemployed -0,1000 0,1800 -0,5600 0,5788 
Mortality IHD 0,0015 0,0001 12,6500 <,0001 
HTNR1 -0,0865 0,0114 -7,6200 <,0001 
HTNR2 0,0006 0,0130 0,0500 0,9603 
HTNR3 0,0141 0,0132 1,0700 0,2853 
HTNR4 -0,1501 0,0114 -13,1300 <,0001 
HTNR5 -0,0025 0,0151 -0,1600 0,8710 
HTNR6 -0,0757 0,0133 -5,6900 <,0001 
HTNR7 -0,0936 0,0122 -7,7000 <,0001 
HTNR8 -0,1031 0,0123 -8,4000 <,0001 
HTNR9 -0,0794 0,0115 -6,9400 <,0001 
HTNR10 -0,1410 0,0120 -11,7500 <,0001 
HTNR11 -0,0068 0,0109 -0,6200 0,5345 
HTNR12 0,0902 0,0131 6,8800 <,0001 
HTNR13 -0,0291 0,0122 -2,3900 0,0168 
HTNR14 0,0927 0,0125 7,3900 <,0001 
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HTNR15 -0,0547 0,0117 -4,6600 <,0001 
HTNR16 -0,0846 0,0102 -8,2900 <,0001 
HTNR17 -0,0852 0,0112 -7,5900 <,0001 
HTNR18 0,0287 0,0121 2,3700 0,0179 
HTNR19 -0,0985 0,0117 -8,4500 <,0001 
HTNR20 -0,0016 0,0103 -0,1500 0,8799 
HTNR21 -0,0266 0,0094 -2,8200 0,0048 
HTNR22 -0,0399 0,0100 -3,9800 <,0001 
HTNR23 0,2269 0,0127 17,8900 <,0001 
HTNR24 0,0000 , , , 
T1999 -0,3065 0,0089 -34,5000 <,0001 
T2000 -0,2795 0,0084 -33,4500 <,0001 
T2001 -0,2327 0,0073 -31,8200 <,0001 
T2002 -0,1722 0,0101 -17,0400 <,0001 
T2003 -0,1207 0,0058 -20,8900 <,0001 
T2004 -0,0684 0,0047 -14,4500 <,0001 
T2005 -0,0284 0,0040 -7,0700 <,0001 
T2006 -0,0018 0,0036 -0,4900 0,6212 
T2007 0,0000 , , , 
* HTNR3 includes Rikshospitalet HT, Ullevål Universitetssykehus HT and Aker 
Universitetssykehus HT due to a subdivision of Oslo in districts. Data on the home 
district of the patients from Oslo municipality is not available. HTNR3 is therefore 
not directly comparable to the results from the other HTs. 
The independent need/demand side variables “Age”, “(Age)2”, “Gender”, “Mortality 
IHD” (p < 0,0001) and “Share 80+” (p < 0,001) are significantly correlated to 
probability of PCI. Need/demand side variables with no significant results are “Share 
45 – 66”, “Share 67 – 79”, “Share disabled”, “Share low education” and “Share 
unemployed”. Of the supply side independent variables, “Distance PCI” is 
significantly correlated to the probability of PCI (p < 0,0001). Eighteen of the HT 
variables (twenty three in total), compared to the dummy variable, are significant at 
the 5% level. The variables explaining the differences between the years, compared to 
the dummy variable, are significant from 1999 to 2005 (2007 dummy). 
The estimate for a given independent variable indicates the percentage change in 
probability of PCI for a one unit increase in the independent variable, while 
controlling for the simultaneous effect of the other independent variables (Newbold, 
Carlson, & Thorne 2006). The interpretation of the estimate (0,0096) for “Age” is 
that for each increase of one year in the age of an AMI-patient the probability of PCI 
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increases with approximately 1%. The older the patient, the higher is the probability 
of PCI. “(Age)2” with its estimate of -0,0001 together with the estimate for “Age” 
show that the probability increases until a certain age where the probability starts 
decreasing instead, see Figure 5.1. The estimates indicate a turning point around 50 
years. 
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Figure 5.1 Probability of PCI as a function of “Age” and “(Age)2”. 
 
The probability of PCI decreases with approximately 2% if the AMI-patient is a 
woman (-0,0190) indicating that in the period of analysis, men are more often given 
PCI for AMI than women. 
If the share of people in age group 80 years and above increases with one unit (1%), 
the probability of PCI decreases with 0,46% (-0,4682). This may indicate what 
Nerland & Hagen (Nerland & Hagen 2008) call a “crowding-effect”. Their study of 
general access to health care services in Norway during the period 1999 – 2005 
established the existence of an effect they called the “crowding-effect”. In 
municipalities with large demand for health care services, waiting lists for treatment 
become longer and the longer the waiting lists, the less consumption per citizen. 
Simplified, larger demand reduces the consumption of health care services because of 
supply side restrictions. If a larger share of the population is in the age group 80 years 
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and above there are most likely more patients in need of general hospital treatment. 
This may generate a lower consumption of treatment due to the “crowding-effect”. 
The negative estimate of the variable “Share 80+” indicates that the consumption of 
also PCI-treatment decreases with increasing need/demand. 
The negative effect of distance to treatment centre (-0,0001) means that if the 
distance increases with 1 km, the probability of PCI decreases with 0,01%. This 
means that longer distance to treatment leads to lower consumption of PCI-treatment, 
ceteris paribus. The estimate for “Mortality IHD” (0,0015) indicates that the 
probability increases with 0,15% with a one unit increase in mortality from IHD. 
5.1 Research question 1 and 2 
The results support a positive answer to the first research question: Is there significant 
evidence for unequal access, measured as varying probability of PCI, in Norway in 
the period of analysis? Significant estimates are found for several of the explanatory 
variables included in the regression analysis, both among the need/demand side 
variables and the supply side variables (see answer to research question 5). 
The HT variables for the whole period of analysis indicate that there are significant 
differences between the probabilities of PCI in some HTs compared to others. HT 
number 24 is chosen as a dummy (value = 0) as the SAS system automatically choose 
the highest variable number as reference unit. Out of the rest 23 HT dummies, five 
are not significant at a 5% level (p > 0,05). Of those HT dummies with a significant 
estimate, the probability of PCI ranges from 0,2269 (HTNR23) to -0,1501 (HTNR4) 
compared to HTNR24. The estimates for the HTs are interpreted as the percentage 
change in probability of PCI compared to the reference unit. Patients living in the 
catchment area of HTNR23 (Universitetssykehuset i Nord-Norge HT) have 
approximately 23% higher probability of PCI than the patients living in the 
catchment area of HTNR24 (Helse Finnmark HT). Patients living in the catchment 
area of HTNR4 (Sykehuset Asker og Bærum HT) have approximately 15% lower 
 68 
probability of PCI than the patients living in catchment area of the reference unit. 
Three HTs distinguish them selves with very high probabilities of PCI; HTNR23 
(Universitetssykehuset i Nord-Norge HT), HTNR14 (Helse Bergen HT) and 
HTNR12 (Stavanger Universitetssykehus HT), see table Table 5.1. 
The estimates from the analysis reveal a clear tendency: The patients living in the 
catchment area of a HT with PCI-treatment have a higher probability of PCI than 
patients living in the catchment areas of a HT without PCI-treatment. This hypothesis 
is tested by including the variable “PCIcentre” in the regression analysis. The 
variable “PCIcentre” includes the HTs with PCI-treatment centre, so that their joint 
effect on the probability of PCI can be distinguished from the effect HTs without 
PCI-treatment centre have on the probability of PCI. The results show that the 
probability of PCI is 12,5% higher (0,1249, p < 0,0001) for a patient living in the 
catchment area of a hospital with PCI-treatment centre, than for a patient living in the 
catchment area of a hospital without PCI-treatment for the whole period. This 
analysis is repeated for the year 2007 separately, and the result gives an estimate of 
16% higher probability (0,1604, p < 0,001) for a patient living in the catchment area 
of a hospital with PCI-treatment centre. 
5.2 Research question 3 and 4 
The same regression analysis is performed for the whole period once more but this 
time the HTs without PCI-treatment centre are excluded from the analysis. The 
analysis would then provide results showing whether or not there is unequal 
probability of PCI within the group of HTs with PCI-treatment centre, controlled for 
all other effects. HTNR23 (Universitetssykehuset i Nord-Norge HT) is chosen as a 
dummy. The results are presented in Table 5.2 . 
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Table 5.2 Results from test of effects within the group of HTs with PCI-
treatment centre, 1999 – 2007. 
Variable Estimate Standard error t-value p-value 
HTNR3 -0,1350 0,0139 -9,7100 <,0001 
HTNR11 -0,1873 0,0117 -15,9900 <,0001 
HTNR12 -0,0236 0,0144 -1,6400 0,1016
HTNR14 -0,0789 0,0117 -6,7300 <,0001 
HTNR18 -0,1633 0,0104 -15,7400 <,0001 
HTNR23 0,0000 , , , 
 
Four out of five HTs have significant estimates (p < 0,001). The estimates show that 
for the whole period there are significant variations in probability of PCI within the 
group of HTs with PCI-treatment centre. Compared to the reference unit, the 
probability ranges from -16,3% to -2,4% lower than the reference. 
Further, all years except the latest year, 2007, are excluded from the analysis. The 
results are presented in Table 5.3. 
Table 5.3 Results from test of effects within the group of HTs with PCI-
treatment centre, 2007. 
Variable Estimate Standard error t-value p-value 
HTNR3 -0,2463 0,1205 -2,0400 0,0410
HTNR11 -0,0794 0,0599 -1,3300 0,1848
HTNR12 -0,0014 0,1177 -0,0100 0,9902
HTNR14 -0,0780 0,0785 -0,9900 0,3206
HTNR18 -0,1806 0,1057 -1,7100 0,0875
HTNR23 0,0000 , , , 
 
Two out of five HTs have significant estimates at a 10% level (p < 0,1). This is 
interpreted as a sign of less variation in the probability of PCI in 2007 than in the 
whole period of analysis, since three out of five do not significantly differ from the 
reference unit.  
Again, the same regression analysis is performed for the whole period, this time the 
HTs with PCI-treatment centre are excluded from the analysis. The analysis would 
then provide results showing whether or not there is unequal probability of PCI 
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within the group of HTs without PCI-treatment centre, controlled for all other effects. 
HTNR24 (Helse Finnmark HT) is chosen as a dummy. The results are presented in  
Table 5.4. 
Table 5.4 Results from test of effects within the group of HTs without PCI-
treatment centre, 1999 – 2007. 
Variable Estimate Standard error t-value p-value 
HFNR1 -0,0399 0,0122 -3,2800 0,0011 
HFNR2 -0,0011 0,0134 -0,0800 0,9371 
HFNR4 -0,0901 0,0126 -7,1700 <,0001 
HFNR5 -0,0089 0,0157 -0,5700 0,5720 
HFNR6 -0,0454 0,0138 -3,2800 0,0010 
HFNR7 -0,0507 0,0129 -3,9300 <,0001 
HFNR7 -0,0627 0,0131 -4,8000 <,0001 
HFNR9 -0,0575 0,0120 -4,7900 <,0001 
HFNR10 -0,0809 0,0129 -6,2700 <,0001 
HFNR11 -0,0342 0,0111 -3,0800 0,0021 
HFNR13 -0,0237 0,0127 -1,8700 0,0613 
HFNR15 -0,0240 0,0123 -1,9500 0,0507 
HFNR16 -0,0788 0,0103 -7,6800 <,0001 
HFNR17 -0,0712 0,0115 -6,1800 <,0001 
HFNR19 -0,0611 0,0123 -4,9700 <,0001 
HFNR20 -0,0094 0,0101 -0,9300 0,3498 
HFNR21 -0,0138 0,0091 -1,5100 0,1311 
HFNR22 -0,0210 0,0102 -2,0700 0,0387 
HFNR24 0,0000 , , , 
 
Thirteen out of eighteen HTs have significant estimates (p < 0,05). The estimates 
show that for the whole period there are significant variations in probability of PCI 
within the group of HTs without PCI-treatment centre. Compared to the reference 
unit, the probability ranged from -9% to -2% lower than the reference. 
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Also for this group, all years except the latest year, 2007, are excluded from the 
analysis. The results are presented in 
Table 5.5. 
Table 5.5 Results from test of effects within the group of HTs without PCI-
treatment centre, 2007.  
Variable Estimate Standard error t-value p-value 
HFNR1 0,0297 0,0393 0,7500 0,4504 
HFNR2 0,0319 0,0561 0,5700 0,5697 
HFNR4 -0,0655 0,0403 -1,6200 0,1044 
HFNR5 0,0381 0,0619 0,6200 0,5380 
HFNR6 -0,0135 0,0448 -0,3000 0,7639 
HFNR7 -0,0041 0,0422 -0,1000 0,9236 
HFNR8 -0,0294 0,0411 -0,7100 0,4754 
HFNR9 0,0094 0,0397 0,2400 0,8133 
HFNR10 -0,0449 0,0416 -1,0800 0,2806 
HFNR13 0,0150 0,0467 0,3200 0,7475 
HFNR15 0,0024 0,0433 0,0500 0,9566 
HFNR16 -0,0597 0,0361 -1,6500 0,0982 
HFNR17 -0,0395 0,0393 -1,0000 0,3151 
HFNR19 -0,0148 0,0403 -0,3700 0,7134 
HFNR20 -0,0078 0,0331 -0,2400 0,8134 
HFNR21 0,0094 0,0303 0,3100 0,7564 
HFNR22 -0,0220 0,0324 -0,6800 0,4971 
HFNR24 0,0000 , , , 
 
None of the HTs have significant estimates. This is interpreted as a sign of only 
insignificant variation in the probability of PCI in 2007 between the HTs without 
PCI-treatment centre. 
The results from the tests within the groups of HTs for the whole period indicate that 
there are significant variations in the probability of PCI both within the group of HTs 
with PCI and within the group of HTs without PCI. The largest variation is found 
within the group of HTs with PCI. The analyses on 2007 data separately, indicate that 
the variation in the probability of PCI within the HTs with PCI seems to be less in 
2007 than for the whole period. For the group of HTs without PCI there are only 
insignificant variations in the probability of PCI in 2007 within the group. 
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5.3 Research question 5 
The positive estimate for “Age” indicates an increase in the probability of PCI with 
older age. The negative estimate for “(Age)2” shows that this trend is declining, 
meaning that the probability increases until a certain age where the probability starts 
decreasing instead. The negative estimate for “Gender” shows that women in less 
extent than men get PCI-treatment. The probability of PCI decreases for a higher 
share of the population being 80 years or older, indicating a lower consumption of 
PCI-treatment due to a “crowding-effect”. The negative effect of distance to PCI-
treatment indicates that longer distance to treatment leads to a lower probability of 
PCI, ceteris paribus. The positive estimate for “Mortality IHD” indicates that the 
probability increases with higher mortality from IHD. 
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6. Discussion 
6.1 Topic and problem statement 
Inequality in the probability of PCI for AMI in Norway during the years 1999 to 
2007 is investigated in this study. This study aimes to assess whether consumption of 
PCI varies with need, or whether the consumption varies with other factors such as 
age, gender, SES, distance to treatment centre and geographical location. 
6.2 Main findings 
Significant estimates (p < 0,001) for the independent variables “Age”, “(Age)2”, 
“Gender”, “Share 80+”, “Mortality IHD” and “Distance PCI” are found. Eighteen 
“HTNR” dummies and seven year dummies are significant at the 5% level. These 
results are used as evidence for claiming that there are significant differences in the 
probability of PCI during the period of analysis. 
In addition, estimates from additional analyses on the whole period indicate that 
patients living in the catchment area of a HT with PCI-treatment have a higher 
probability of PCI than patients living in the catchment areas of a HT without PCI-
treatment. This difference seems to increase from 1999 – 2007. 
Significant variations in the probability of PCI both within the group of HTs with PCI 
and within the group of HTs without PCI are found. The largest variation is found 
within the group of HTs with PCI. The variation in the probability of PCI within the 
two groups decreases from 1999 – 2007. 
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6.3 Discussion of results 
The estimates for the variables “Age”, “(Age)2” and “Gender” are as anticipated. The 
results from “Age” and “(Age)2” presented in Figure 5.1 indicate that the probability 
decreases after an age of 50 years. One possible explanation is that having an AMI 
before the age of 50 generates more extensive treatment methods than an AMI case 
where the patient is older. Cost-utility analysis favours resources spent on young 
patients compared to older patients, number of QALYs7 being higher for younger 
patients. There might also be that those experiencing an AMI before the age of 50 
have a more serious AMI and therefore are in greater need of PCI than patients older 
than 50 years with less serious AMI cases. Another explanation might be that the risk 
of complications is higher for older patients and therefore PCI-treatment are given in 
less extent to older patients. More research is needed to draw any conclusions about 
the explanation. 
The estimate for “Gender” shows that women are more seldom given PCI-treatment 
than men. The fact that women have a lower probability of PCI is not necessarily a 
signal of inequality. Since women with AMI often experience a more diffuse disease 
where PCI is not the best treatment method, a lower probability for women may not 
indicate inequality after all. Further investigation of the medical aspects of 
differences in treatment between men and women due to differences in AMI disease 
factors is outside the scope of this study. 
The estimate for “Share 80+” is as anticipated negative. This result can be interpreted 
as a “crowding-effect” where higher demand is not met by a correspondingly higher 
supply and inequalities arise. The descriptive statistics (see chapter 4.9) for age 
groups, however, shows that there is a larger percentage in older age groups getting 
PCI in 2007 than in 1999. 
                                              
7 Quality-adjusted life years (QALYs) is a measure of disease burden, including both the quality and the quantity of life 
lived. 
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As anticipated, the estimate for “Distance PCI” is negative. Some of this effect is 
assigned to the medical guidelines (see chapter 2.4) recommending thrombolytic 
treatment if there is more than 90 minutes travel time to a hospital with PCI-
treatment. Whether some of this effect should also be assigned differences in medical 
practice due to for instance distance to treatment centre is discussed in connection 
with the HT-variables. 
The positive estimate for “Mortality IHD” means that areas with a higher demand for 
PCI have a higher probability of PCI, indicating a better supply than in areas with 
less demand. This must be interpreted as a “healthy” sign for the health care sector in 
Norway, indicating that the health policy makers, the responsible for prioritizing 
within health care and those responsible for resource allocation to a certain extent 
manage to establish a better supply of health care services in areas with higher 
need/demand. 
The regression analyses run on the two groups of HTs (with and without PCI-
treatment centre) reveal a significant difference in the probability of PCI for patients 
living in the catchment area of a HT with PCI-treatment compared to patients living 
in the catchment area of a HT without PCI-treatment. The result is controlled for the 
other variables included in the analysis, which means that there must be some 
unidentified explanatory factors affecting the probability of PCI. As mentioned in 4.2 
there may be generated more AMI admissions than is the case in HTs without PCI-
treatment. The result may be that the difference between HTs with and HTs without 
PCI-treatment in reality is not as significant as this analysis shows. The trend of 
larger differences over time may thus be a sign of increasing division of in-patient 
stays. Instead of recovering at the PCI-treatment centre, the patients may experience 
being sent to another local hospital for recovery. Another explanation of the 
difference may be different medical practice, for example in referrals for PCI and use 
of thrombolytic treatment between the HTs. If the difference is caused by the latter, 
inequality in the access to PCI treatment is found. Further investigation is needed 
before a final conclusion can be made about the reasons for these differences.  
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Analysing the differences within the two groups of HTs reveal differences also within 
each group. The largest difference in probability of PCI is found within the group of 
HTs with PCI-treatment. This result is mainly caused by HTNR23 
(Universitetssykehuset i Nord-Norge HT) and HTNR12 (Stavanger 
Universitetssykehus HT) which stand out with the significant highest probabilities of 
PCI. Again, differences in medical practice may explain the findings. Such 
differences should be investigated further, especially the possibility of different 
treatments for the same AMI severity. Evidence for medical practice including PCI-
treatment for lower severity cases of AMI in some HTs compared to others would 
indicate inequality in the probability of PCI between the HTs. Another possible cause 
is a trend including healthier lifestyle. If this is a trend spreading across the country, 
starting in the main cities and perhaps being correlated to high SES, results of this 
may be less serious and fewer AMI cases in the areas where the population are more 
health conscious. Areas not reached by this trend yet, may experience more serious 
AMI cases and a higher number of AMI. 
Noticing that the HT with the highest probability of PCI is HTNR23 
(Universitetssykehuset i Nord-Norge HT) draws the attention towards the financing 
of the North Norway RHA mentioned in chapter 3.2. Due to need based analyses this 
region is assigned more resources than the analyses have found need based evidence 
for. Whether or not this has established a better supply of health care services, in this 
case PCI-treatment, in this region when compared to other regions is not known for 
certain. But favourable financing of the North Norway RHA may be a possible 
explanation of the differences in probability of PCI found in this study. 
Looking at the analyses of the two groups of HTs for the year 2007 separately, 
differences within the two groups seem to decrease until almost no difference in the 
probability of PCI because very few of the variables significantly differed from the 
reference unit.  
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6.4 Limitations 
The results must be interpreted with several reservations. Significant explanatory 
variables not included in the analysis are a general problem for regression analyses. 
The independent variables included in this analysis are chosen on the basis of 
available research and earlier findings on this field. There might however, exist some 
significant explanatory variables that should have been included, but is not. Local 
variables explaining AMI incidence or PCI demand within a small area may be 
examples of such variables. These possible effects are tried captured by dummies 
(fixed-effects) for HTs and years. 
Researchers should bear in mind that the NPR-data is constructed mainly for financial 
purposes (reimbursements due to ABF). Medical information gathered from NPR-
data should therefore be interpreted carefully with this in mind. Choosing the 
diagnosis AMI and the treatment PCI as the field of investigation minimized the 
chances of systematic errors due to differences in coding praxis from year to year or 
from HT to HT. The coding praxis at this field is very clear and has not been changed 
considerably during the period of analysis. The use of NPR-data in analyses is briefly 
discussed in chapter 4.2 where the problem with double/triple registration of AMI 
cases is mentioned. This means that the probability of PCI for municipalities within 
the catchment area of a hospital not offering PCI-treatment may show a false low rate 
because of a higher AMI number than is the case. HT dummies are included in the 
analysis to capture some of these effects. An additional analysis between the HTs not 
offering PCI and between the HTs offering PCI is executed to investigate the 
differences between the two groups further. 
The lack of direct information about the need for PCI-treatment in the different 
municipalities constitutes a problem. Variations in probability of getting PCI-
treatment can be difficult to interpret since they may be justified if associated with 
variations in incidence. Mortality data on IHD is included in the analysis as an 
independent variable and analysed for its effect on the probability. In this way the 
estimates from the analysis are controlled for need, measured as mortality from IHD. 
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Exact information about the incidence would have lead to an even better and more 
reliable result. 
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7. Conclusion 
Significant evidence for inequality in the probability of PCI is found in this study. 
Differences between the HTs and a decreasing probability with increasing distance to 
PCI-treatment centre indicate that place (geographical location) do matter when 
looking at inequality in the access to PCI-treatment. No significant estimates are 
found for the SES-variables, indicating that SES does not matter for the probability of 
PCI. Differences in probability of PCI are also found for age, gender, share above 80 
years, mortality from IHD and years. The differences are relatively large in the 
beginning of the period. Due to decreasing differences with time, the differences are 
relatively small in the end of the period of analysis. 
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Appendix 
7.1 HT numbers, name and PCI-centre 
HTN
R  Name Hospital Trust/area PCI-centre 
1 Sykehuset Østfold HT   
2 Akershus Universitetssykehus HT   
3 Oslo* 
Yes 
(Rikshospitalet, 
Ullevål). No 
(Aker). 
4 Sykehuset Innlandet HT   
5 Sykehuset Asker og Bærum HT   
6 Ringerike Sykehus HT   
7 Sykehuset Buskerud HT   
8 Blefjell Sykehus HT   
9 Sykehuset i Vestfold HT   
10 Sykehuset Telemark HT   
11 Sørlandet Sykehus HT 
1999: No. 2007: 
Yes. 
12 Stavanger Universitetssykehus HT Yes 
13 Helse Fonna HT   
14 Helse Bergen HT Yes 
15 Helse Førde HT   
16 Helse Sunnmøre HT   
17 Helse Nordmøre og Romsdal HT   
18 St. Olavs Hospital HT Yes 
19 Helse Nord-Trøndelag HT   
20 Helgelandssykehuset HT   
21 Nordlandssykehuset HT   
22 Hålogalandssykehuset HT   
23 
Universitetssykehuset Nord-Norge 
HT Yes 
24 Helse Finnmark HT   
* HTNR3 includes Rikshospitalet HT, Ullevål Universitetssykehus HT and Aker 
Universitetssykehus HT due to a subdivision of Oslo in districts. Data on the home 
district of the patients from Oslo municipality is not available. 
